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ABSTRACT OF DISSERTATION

HUMAN CARDIOVASCULAR RESPONSES
TO
ARTIFICIAL GRAVITY TRIANING
Human cardiovascular adaptations to microgravity include decreased plasma volume,
exercise capacity, baroreflex function as well as decreased orthostatic tolerance upon
return to a gravity environment. Several countermeasures have been proposed and tested,
although currently none have been developed to prevent post-spaceflight orthostatic
intolerance (OI). Artificial gravity (AG) generated by short-radius centrifugation (SRC)
has been proposed as a countermeasure to OI as well as other cardiovascular alterations.
Methods: Fifteen men and fourteen women underwent three weeks of daily (5 days a
week) exposure to intermittent (1.0 to 2.5 Gz) artificial gravity on a 1.9m human powered
centrifuge (HPC) at the NASA Ames Research Center. Half the subjects exercised
(active) to power the HPC while half rode passively (passive). A combination head-up
tilt (HUT) and lower body negative pressure (LBNP) test was used to determine
orthostatic tolerance before and after training. Oscillatory LBNP (OLBNP) was used at
seven frequencies (0.01 to 0.15 Hz) for two minutes each to assess the dynamic responses
of the cardiovascular system to orthostatic stress, before and after AG training. Results:
Training improved overall tolerance in the group of subjects by 13% (p<0.05); men were
more tolerant than were women (p<0.05); and active subjects were more improved than
passive subjects (p<0.05). Mechanisms of improvement appear to be through decreased
total peripheral resistance (TPR) and increased stroke volume after training, and
increased responsiveness of TPR to fluid shifts (faster changes in TPR to changes in calf

circumference [CC] and OLBNP after training). There was no change in spontaneous
baroreflex sensitivity (BRS, calculated by sequence method) or number of sequences per
number of heart beats (NNS), although BRS analysis did indicate that stimulation to the
cardiac baroreceptors during 1.0 Gz and 2.5 Gz centrifugation was no different than
supine control and 70º HUT, respectively. Taken together, these results suggest that AG
training improved tolerance through training of local mechanisms in the peripheral
vasculature, or extrinsic control of peripheral vascular resistance, rather than through
changes of autonomic control of heart rate.
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Chapter 1: Introduction

Space, and Earth’s position in the cosmos has always been a topic of interest (and
dispute) throughout mankind’s history. In On the Heavens, Aristotle (384-322 B.C.)
described the earth as being the center of the universe, with all of the other heavenly
bodies revolving around us in circular orbits (67). This geocentric theory was modified
by Ptolemy (87-150 A.D.) and accepted as fact until the early 16th century when Nicolaus
Copernicus came up with a heliocentric model in which the earth revolves around the sun
(68). Nearly 100 years later, Galileo Galilei used telescopes to observe that not all
celestial bodies revolve around the earth, and he accepted that the geocentric theory could
not be correct (63). One of Galileo’s contemporaries, Johannes Kepler corroborated his
findings, determining that the earth and the other planets revolved around the sun in an
elliptical orbit. Despite the overwhelming scientific evidence, this was still an issue of
much contention. The dispute was finally laid to rest in 1687 with the publication of Sir
Isaac Newton’s Philosophiae Naturalis Principia Mathematica, in which he theorized the
movement of bodies in space, and developed mathematical equations for proof (67).
After millennia of thinking that the earth was at the center of the galaxy, mankind has
made giant leaps in its knowledge and understanding of the earth and galaxy.
Only half a century ago man developed the technology to finally travel into space.
Led by the Russian cosmonaut Yuri Gagarian in April of 1961, and followed by
American Alan Shepard only a month later, humans broke the bonds of Earth and entered
space for the first time. Since then, humans have set foot on the moon, lived in space
stations orbiting the planet and made hundreds of trips into space.

Even more

astounding, private civilians developed SpaceShipOne in 2004, the first civilian vehicle
to reach space (35). With the growing projected number of humans in space (including
people with varied physiological makeup and fitness), and the desire to explore farther
away from Earth, the issue of human safety and space travel needs continued
investigation.
While some dangers of space travel are obvious--space radiation, extreme
temperatures and vacuum, lift-off, re-entry and landing, to name a few (109, 149); there
1

are a host of physiological adaptations that the body undergoes in a microgravity
environment that are potentially harmful. Exposure to microgravity can cause muscle
atrophy (36, 80, 87, 123), bone demineralization (69, 70, 80, 137) (kidney stones due to
high calcium filtration secondary to demineralization), decreased immune function (6, 17,
109, 113), neurovestibular defects (85, 100, 130) and impaired cardiovascular function
(7, 10, 21, 37, 40, 46-48, 62, 90, 92, 104, 109, 131, 137, 142, 149); i.e., decreased plasma
volume and red cell count, decreased autonomic function, cardiac arrhythmias and
decreased orthostatic tolerance upon return to a gravity environment.

These

physiological adaptations can decrease astronaut work performance and efficiency as
well as endanger crew safety. Some countermeasures have been developed to, if not
prevent, at least to ameliorate several of these microgravity-induced impairments. For
example, exercise is used to maintain work capacity, and especially when combined with
lower body negative pressure, mitigate muscle atrophy and bone loss (22, 33, 97).
Ingestion of salt tablets and fluid retaining drugs such as fludrocortisone have been used
to restore plasma volume (110, 125) before re-entry. Pressurized G-suits are routinely
used to help maintain orthostatic tolerance upon landing, but this benefit goes away once
the astronaut takes the suit off. As yet there is no operationally-accepted countermeasure
to prevent the orthostatic intolerance and many other physiological changes associated
with spaceflight deconditioning.

Objective
There has been discussion that some form of artificial gravity would help to
prevent many of the detrimental effects of spaceflight (11, 13, 14, 16, 34, 76, 79, 83, 84,
128, 145, 146). The use of a short radius centrifuge (radius of approximately body
length) to produce centripetal forces along the spinal axis is of growing interest to NASA.
The purpose of the research described in this document is to determine if artificial gravity
generated by a short-radius centrifuge (SRC) affects cardiovascular function of normal,
ambulatory human subjects.

To this extent, measurements were made of the static

orthostatic responses (to a combination of head-up tilt and lower body negative pressure)
as well as dynamic responses (to 7 different lower body negative pressure input
frequencies ranging from 0.01 Hz to 0.15 Hz) in 15 men and 14 women before and after
2

3 weeks of daily, intermittent exposure to artificial gravity via short-radius centrifugation.
The hypothesis for this study is that 3 weeks of training will improve orthostatic
tolerance. The primary goal of this research is to determine the mechanisms associated
with the hypothesized improvement.

3

Chapter 2: Background
Physiological Responses to Orthostatic Stress
Standing up from a supine position in a gravity field (i.e. on earth) imposes a
substantial challenge to the human cardiovascular system.

Due to the increase in

hydrostatic pressure gradient acting along the length of the body, venous volume
increases by approximately 500 mL (105). This redistribution of fluid from the central
circulation is immediately detected by baroreceptors (pressure) and, in time, by volume
(osmolarity) receptors activating reflex responses to increase heart rate, contractility and
vascular resistance as well as to maintain blood volume. This response is described in
detail below.
The carotid, aortic and cardiopulmonary baroreceptors are sensitive stretch
receptors, which can detect increases or decreases in arterial pressure. The afferent fibers
from carotid baroreceptors transmit signals to the nucleus tractus solitarius (NTS) via the
glossopharyngeal nerve, while afferents from the aortic arch and pulmonary system
transmit through the Xth cranial nerve, the vagus (89). Most cardiac afferents synapse at
the NTS, where information is assimilated and parasympathetic outflow is relayed to the
nucleus ambiguus (NA, location of vagal motor neurons) and sympathetic outflow is
relayed to the caudal ventrolateral medulla (CVLM). Sympathetic neurons in the spinal
cord are tonically excited by input from the rostral ventrolateral medulla (RVLM). In
turn, RVLM outflow is mediated by the CVLM via the inhibitory neurotransmitter γaminobutyric acid (GABA) (89).

Depending on the afferent input to the NTS,

sympathetic outflow from the RVLM can be modulated through the CVLM, and there is
evidence of a direct inhibitory pathway to the spinal motor neurons through the raphe
nuclei (89).
At the level of the heart, the right vagus synapses at the sinoatrial (SA) node,
which is the pacemaker node. The left vagus synapses near the atrioventricular (AV)
node which controls the conduction velocity to the ventricles. The parasympathetic
neurotransmitter is acetylcholine (ACh) which binds to muscarinic receptors in these
pacemaker cells.

Acetylcholine slows heart rate through two G-protein second

4

messenger systems; one is an inhibitory G-protein which reduces the slope of the
depolarizing current in the pacemaker cells by inhibiting cAMP modulation (via reduced
adenylate cyclase activity) of depolarizing sodium influx and the second is a stimulatory
G-protein which hyperpolarizes pacemaker cells by increasing potassium efflux. Both of
these result in a reduction of heart rate.
The pre-ganglionic sympathetic neurons to the heart synapse in the thoracic spinal
column, T1 to T5 (89). The post-ganglionic neurons innervate the whole heart (i.e.,
myocardial cells of the ventricles, atria and electrical system) as opposed to the nodal
innervation of parasympathetic neurons.

Norepinephrine (NOR) is the sympathetic

neurotransmitter, which binds to β1 receptors in the heart. Its chronotropic effect is
opposite to that of ACh in that β1 receptors stimulate adenylate cyclase, which increases
the conversion of ATP to cAMP, leading to an increase in sodium influx. This increased
sodium current increases the slope of the depolarizing current, which increases heart rate.
Norepinephrine also increases chronotropism through increased AV conduction velocity
and decreased myocyte action potential duration via early repolarization (89).
Sympathetic-stimulated increase in cAMP also has an inotropic effect; cAMP
phosphorylates protein kinase A (PKA), which increases calcium influx into the
myocytes through calcium channels. PKA also phosphorylates phospholamban, which
causes the sarcoplasmic reticulum (SR) to remove free calcium from within the cell
faster. Over the course of a few heart beats, this increases SR calcium (mainly due to SR
storage of extracellular calcium), which leads to stronger contractions. It is clear that
sympathetic activity has a longer biochemical second messenger chain to act through, and
this partially explains why it is slower to respond than the parasympathetic system, which
can respond within a heart beat (5). Epinephrine, released from the adrenal medulla, has
an effect very similar to norepinephrine at the cardiac level.
At the arteriolar and venule level, sympathetic neural activity controls vascular
resistance through contraction and relaxation of vascular smooth muscle (VSM) cells.
The post-ganglionic sympathetic neurotransmitter, norepinephrine, binds to αadrenoreceptors on the surface of VSM cells. These receptors act through two G-proteins
to cause muscle contraction; 1) directly increasing calcium channel influx of calcium and
2) activation of phospholipase C which catalyzes the conversion of phosphatidyl inositol

5

bisphosphate (PIP2) to inositol triphosphate (IP3) and diacyl glycerol (DAG).

IP3

stimulates the release of calcium from intracellular SR, which along with extracellular
calcium triggers contraction. DAG activates protein kinase C which helps to sustain
longer contractions (89).
Unlike its action at the heart, epinephrine can have an effect opposite to
norepinephrine when acting on peripheral blood vessels.

Epinephrine binds to β2

receptors as well as α-adrenoreceptors in the vasculature. In areas of high β2 density,
such as in skeletal muscle and the liver, epinephrine can cause vasodilation (89).
Vasodilation in VSM is a G-protein coupled process. β2-adrenoreceptor activation causes
an adenylate cyclase-mediated conversion of ATP to cAMP, which in turn activates
protein kinase A. This phosphorylates the activation of Ca-ATPases in the SR and the
cell wall, reducing intracellular calcium levels and thereby causing vasodilation. Other
vasodilators act through the cAMP pathway, including adenosine, histamine, vasoactive
intestinal polypeptide (VIP) and calcitonin-gene related peptide (CGRP).

Another

powerful vasodilator, nitric oxide (NO), acts in a different manner. Rather than being
coupled to a G-protein complex, NO diffuses through the VSM membrane and activates
protein kinase G, which is thought to act in the same fashion as protein kinase A (89).
Concurrent with the neural response, is the endocrine response. Sympathetic
outflow releases epinephrine and norepinephrine from the adrenal medulla gland. The
action of these two catecholamines is described above. Renal sympathetic nerve activity
stimulates the release of renin which converts angiotensinogen to angiotensin I.
Angiotensin I is eventually converted to Angiotensin II (AII) in the lungs. Angiotensin II
plays two key roles in cardiovascular control; it is a potent vasoconstrictor, and it
stimulates aldosterone secretion, which stimulates sodium and water retention in the
kidneys.
In addition to stimulating the baroreceptor response, standing can eventually
trigger osmolarity receptors, located in the hypothalamus, which mediate the release of
vasopressin. Vasopressin, also known as anti-diuretic hormone, stimulates the kidneys to
retain water. Vasopressin can also act as a vasoconstrictor in most tissues, except for the
cerebral and coronary vessels where it actually has a vasodilatory effect (89). This is an
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appropriate response, as it redistributes blood to the heart and brain in cases of
hypovolemia.
Considering again a person standing in a gravity environment, a decrease in blood
pressure is countered by parasympathetic withdrawal and sympathetic activation. Reflex
activity then leads to a faster and stronger heart beat, coupled with an increase in vascular
(in both arterioles and venules) resistance, and hormonal activation to maintain plasma
volume. This total reflex helps to maintain perfusion to the brain. It is important to note
that the most important regulator of blood pressure is the vascular resistance response
(105). Increasing vascular resistance results in decreased filtration at the capillary level
which can lead to increased venous return to the heart. If vascular resistance did not
increase, increasing heart rate would not increase cardiac output as stroke volume would
continue to fall due to the lack of filling pressure.
In humans, the splanchnic region is the most compliant, and therefore capable of
retaining the largest amount of blood volume. The greatest percentage of total body fluid
conductance is in the splanchnic region (25%) with the renal system and skeletal muscle
each containing about 20% of the total conductance (105). It is these regions, therefore,
that vasoconstrictor activity is most important in order to shift fluid to the upper thorax
and brain. In the legs, contraction of muscles upon standing helps to increase venous
return by compressing the veins; one way valves in the veins allow blood to travel in one
direction only—towards the heart.
In summary, the reflex response to standing in a 1 Gz environment is increasing
heart rate and cardiac contractility, vascular resistance and blood volume, all in an
attempt to maintain cerebral perfusion. If cerebral perfusion is compromised, as is often
the case in astronauts returning from space, syncope, or fainting, can occur.

Cardiovascular Deconditioning in Microgravity
Due to the limited nature of data from actual spaceflights, there are some
conflicting theories on the exact mechanisms of cardiovascular adaptation to
microgravity. In general, the absence of Earth’s gravity gradient shifts fluid from the
peripheral vasculature to the upper thorax (19, 24, 64, 96, 122). One would expect
volume contraction via diuresis, but reduced fluid ingestion, and in some cases, emesis
7

from space motion sickness, are major contributors to reduced volume (134). Loss of
total fluid volume, as well as interstitial filtration (131), causes plasma volume
contraction and lowering of central venous pressure (21, 30, 31).
This loss of plasma volume is associated with a 10 – 20% decrease in stroke
volume (134), and surprisingly, a decrease in resting heart rate (48, 62) which appears to
be vagally dominated (62). The decrease in heart rate is surprising, especially in light of
increased total sympathetic outflow (40) which increases calf vascular resistance(133)
and in the long term, a reduction in leg volume (96, 122). Another cause for reduction in
leg volume is muscle atrophy (36, 86, 123), which is thought to increase overall leg
compliance, a key player in post-spaceflight hypotension (134).

The next section

describes in detail the altered physiological response to orthostatic stress after extended
exposure to microgravity.

Physiological Responses to Standing after Deconditioning
Due to the adaptations to microgravity, many astronauts develop presyncopal
symptoms upon returning to Earth. The deleterious effects of spaceflight on orthostatic
tolerance depend on the duration of microgravity exposure and the type of orthostatic test
used. Buckey et al. reported 9 out of 14 astronauts were unable to withstand a 10 minute
stand test after 9-14 days in space (7). Meck et al. reported that 4 of 5 astronauts become
syncopal after long duration spaceflight (129 – 190 days) while only 1 out of these same
5 became syncopal during a short duration spaceflight (91); both tests were 10 minute
stand tests. In two separate studies, Meck et al. report post-flight orthostatic intolerance
to the 10 minute stand test in 4 out of 16 and 10 out of 23 astronauts (47, 92). Levine et
al. studied 6 astronauts after 16 days in space, and reported no cases of syncope;
however, it is important to note that they used a 60º passive head-up tilt with one leg
bearing the full load of a subject’s weight (the second leg was elevated for
microneurography measurements), which could stimulate a stronger reflex response than
passive stand tests, in which astronauts are instructed to relax leg muscles (90).
In all cases, post-flight orthostatic testing is characterized by a greater increase in
heart rate and decrease in stroke volume (7, 47, 90-92, 142). Although heart rate is
elevated after spaceflight, there is evidence that this baroreflex mediated response is
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altered adversely by spaceflight (7, 46, 48). At the same time, however, sympathetic
outflow is intact and responds appropriately (40, 50, 90, 142) to the orthostatic stress.
Even though sympathetic outflow is intact, it is possible that it is not sufficient to
maintain peripheral vascular resistance. There is evidence of increased norepinephrine
release without concomitant increase in vascular tone (142) suggesting a decrease in αadrenoreceptor (92, 142) or increased β-adrenoreceptor responsiveness (104).
Vascular resistance has been determined to be one of the key factors in
distinguishing “finishers” (those able to withstand the 10 minute stand test) from “nonfinishers” (those unable to withstand the 10 minute stand test). Several researchers have
noted that “finishers” tend to have higher total peripheral resistance than “non-finishers”
(7, 91, 92, 136) during the stand test after spaceflight. Moreover, recent research shows
that application of midodrine, an α1 agonist, increased vascular resistance and improved
orthostatic tolerance in a previously orthostatically-intolerant astronaut — lending
strength to the role of vascular resistance in maintaining orthostatic tolerance after
spaceflight (101).

Gender Differences in Physiological Responses to Orthostatic Stress
There are several well documented differences between male and female human
responses to orthostatic stress, most notably that men are more tolerant than women (23,
43, 49, 93, 136, 139). There are contributing factors to the female predilection to faint
that have been documented, both in baseline control values and in the response to
orthostatic stress (i.e. lower body negative pressure, head-up tilt or stand test). Men tend
to have higher resting blood pressure (49, 54, 55, 93, 95, 112, 136) as well as increased
pressure in response to orthostatic stress (23, 55, 111, 136); women tend to have higher
resting heart rate (93, 95, 112, 136) and increased heart rate response to orthostatic stress
(45, 93, 111). While baseline levels of vascular resistance appear to be the same, several
reports indicated that men have a higher vasoconstrictive response to hypotensive
challenges than do women (45, 55, 93, 136) while others report no differences in the
vasoconstrictive response between genders (23, 49, 111).
Reports of increased norepinephrine levels during hypotensive stress would
support the idea of increased vasoconstrictor response in men (23, 136) while still others
9

report no gender differences in circulating norepinephrine levels during orthostatic stress
(49, 53). However, there is some evidence for differences in the vascular responsiveness
to circulating levels of catecholamines. One report indicates strong vasoconstrictive
responses to α-adrenergic agonists phenylephrine and clonidine in men, while showing
no response in women (44).

The same report shows that men also have greater

responsiveness than women to the β-adrenergic agonist isoproterenol.

One of the

contributing factors to decreased orthostatic tolerance in females is probably their
hypoadrenergic response to stress (44, 92, 136), which may be confounded by the
vasodilatory effect of circulating estrogen (129, 143, 144). Additionally, women tend to
pool more blood in the splanchnic area, which could also adversely affect orthostatic
tolerance (93, 139).

Previous Countermeasures
One of the most dangerous effects of cardiovascular deconditioning, especially in
the context of space shuttle landing or emergency egress in a gravity environment, is
orthostatic intolerance. There have been several countermeasures developed that have
attempted to prevent this. One successful countermeasure is the use of G-suits, which
work by applying positive pressure to the legs and lower thorax, thereby aiding in venous
return and maintaining cerebral perfusion (32). However, these effects are only transient,
and disappear once the G-suit is removed after landing.
One of the underlying reasons for post-flight orthostatic intolerance is
hypovolemia, and various attempts have been made to restore plasma volume. Ingestion
of salt water (8 grams of NaCl with 960 mL of water) before re-entry has been shown to
restore plasma volume and prevent orthostatic hypotension in a flight of less than 7 days
(9). However, the benefits of saline loading disappear during long flights (141). There
have been mixed results to saline loading in simulated microgravity (6º head-down bed
rest) studies. Using the same protocol that U.S. astronauts use (8, 1 gram NaCl tables in
960 mL of water), Vernikos et al determined that this method was insufficient to restore
plasma volume (and orthostatic tolerance) to pre-bed rest levels (125). However, by
basing saline ingestion on body weight instead of limiting it to the standard 960 mL,
Waters et al were able to restore plasma volume and prevent orthostatic intolerance in a
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similar simulated microgravity study (135). It is important to note that, even though
studies in simulated microgravity are many times similar to actual results from a
microgravity environment, results are not always similar. The use of fludrocortisone has
been shown to prevent plasma volume loss (and hence maintain orthostatic tolerance) in a
simulated microgravity study (125), but the same protocol used in an actual spaceflight
environment did not improve orthostatic intolerance (110).
It is likely that plasma volume restoration alone is not sufficient to prevent
spaceflight-induced orthostatic intolerance; some form of stimulation or stress to the
cardiovascular system is likely needed to attenuate deconditioning in microgravity.
Lower body negative pressure (LBNP) has been proposed as a means of generating a
head-to-foot force (65) and is well known for displacing fluid to the lower body and
thereby stimulating the cardiovascular system (25, 60, 61, 65). Application of LBNP has
been shown to be effective in spaceflight and ground based studies to prevent orthostatic
hypotension (3, 42, 59-61, 71, 119). However, the duration and frequency of required
LBNP stimulation makes it unattractive during spaceflight, where time is already limited
(20, 84).
Another countermeasure that is currently being used, but it not completely
effective in preventing post-flight hypotension, is aerobic exercise (15, 22, 33, 58, 107).
Astronauts exercise either on a stationary bicycle or treadmill, and can perform isokinetic
training with spring resistance devices (33). This method of moderate intensity exercise
for long durations is effective in maintaining work capacity, but not in maintaining
orthostatic tolerance. When studied in ground based simulations of microgravity, an
acute bout of maximal exercise one day before the end of the study was shown to be
effective in restoring plasma volume and orthostatic tolerance to pre-bed rest levels (27,
29, 33, 38, 39). Although this countermeasure did not elucidate greater tolerance than
control subjects after spaceflight, it did increase cardiac output and stroke volume, and
shows merit for future use (94).
Perhaps the most logical countermeasure to deconditioning in a microgravity
environment is to use an artificial gravity source to stimulate the cardiovascular system.
Based largely on the relatively small payload capabilities of current space transports, a
short radius, or short arm centrifuge (SRC) has been suggested to provide artificial
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gravity in space (11, 12, 14, 66, 75, 76, 132, 145). The idea of short arm centrifugation is
not a new one; in 1966, White et al showed that periodic centrifugation from 1 Gz to 4 Gz
for 20 minutes a day, 4 times a day during 41 days of bed rest prevented the expected
orthostatic intolerance after bed rest (140). In the same year, Piemme et al determined
that human tolerance on a 4 foot, 9 inch centrifuge ranged from a couple hours at 4 Gz to
several minutes at 7 Gz (99).
One of the unknowns in the field of SRC research is the amount of centrifugation,
both duration and magnitude, needed to prevent the detrimental effects of microgravity.
Hastreiter and Young determined that 1.5 Gz (at the feet) was required to simulate calf
blood flow changes similar to standing (66). In a head-down bed rest study, 2 hours a
day of passive standing was sufficient to prevent post-bed rest hypotension, although 4
hours a day of passive standing was required to maintain plasma volume (124). Two
hours of standing also prevented simulated microgravity effects in a rat tail-suspension
study (147). In another non-human study, Korolkov et al studied primates during 4
weeks of HDBR (83). They determined that short radius centrifugation was successful in
preventing extracellular fluid loss and orthostatic hypotension resulting from bed-rest.
More interestingly, they determined that 1.2 Gz, 3 times a week may be more effective
than higher Gz levels, 4 to 5 times a week (83).
In a simulated microgravity study, Iwasaki et al determined that 1 hour of
exposure to 2 Gz on an SRC was sufficient to prevent the negative effects of 6º head
down bed rest (HDBR) on baroreflex function and plasma volume, although this
countermeasure alone was not sufficient to maintain exercise capacity (75); however,
another study showed that combining acceleration with moderate exercise helped to
maintain upright exercise responses (79). Furthermore, Vil-Viliams showed that exercise
combined with centrifugation at 0.8, 1.2 and 1.6 Gz was effective in maintaining
orthostatic tolerance from 3 to 28 days of head out water immersion (127).
It is generally accepted that some form of artificial gravity will be effective in
ameliorating many of the detrimental effects of spaceflight, not only on the
cardiovascular system, but most physiological systems. Current research goals are to
determine what kind of artificial gravity is necessary; how much is sufficient, and for
how long?
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Research by Our Laboratory
Based on the current knowledge presented in the literature, our laboratory
recognized the advantage of short radius centrifugation as a countermeasure to
spaceflight deconditioning. We therefore participated in a study that used a 1.9 meter
SRC to document the effects of 3 weeks of acceleration training with, and without,
exercise on the cardiovascular response to one hour of 70º head-up tilt (HUT) on normal,
ambulatory male volunteers (57, 118). We determined that intermittent acceleration (7
cycles of 2 minutes at 1 Gz followed by 2 minutes at 2.5 Gz) for 3 weeks improved
orthostatic tolerance and baroreflex activity (118), both of which are known to be
attenuated after spaceflight (46) and bed rest (75).

Rationale
One of the shortcomings of the above study was that a one hour time limit was
placed on the orthostatic stress test, and the test was terminated at this point, regardless of
outcome.

Therefore, we were unable to get an accurate assessment of the effect

acceleration training had on orthostatic tolerance, as many subjects withstood the hourlong HUT both before and after the training protocol. Secondly, this study was only
performed on men, and thirdly, only the static responses (to a 70º head-up tilt) of training
effects on the cardiovascular system were assessed.
The purpose of the present study was to determine cardiovascular responses of
ambulatory humans to 3 weeks of intermittent acceleration training (described above)
with and without exercise. More specifically, lower body negative pressure was coupled
with head-up tilt to bring all subjects to a pre-syncopal endpoint, in order to determine an
accurate assessment of artificial gravity training (with and without exercise) on
orthostatic stress tolerance time. Secondly, oscillatory lower body negative pressure was
used at 7 different frequencies from 0.01 to 0.15 Hz, to assess the dynamic response of
the cardiovascular system before and after artificial gravity training. Thirdly, 15 men and
14 women were studied in order to elucidate any gender differences in these
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cardiovascular responses before and after artificial gravity training. Specifically the
present study was designed to discriminate interactions between before/after training,
men/women and exercise/non-exercise effects of artificial gravity training.
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Chapter 3: Methods
Subjects
Twenty-nine volunteers began this study, 15 male and 14 female. One male
subject was removed from the study for failing to comply with study regulations, and one
female subject voluntarily withdrew herself. Data from a second female subject was
discarded because of excessive pre-ventricular contractions when studied. Results are
reported for data from a total of 26 subjects, 14 male and 12 female.
All subjects were normal, healthy volunteers and were screened for
cardiovascular health and absence of drug and alcohol use (including tobacco). Men
were 32.4 ± 2.6 years old, 180.4 ± 1.4 cm tall and weighed 81.2 ± 2.0 kg. Women were
31.7 ± 1.8 years old, 164.7 ± 4.12 cm tall and weighed 61.45 ± 19.3 kg. Male subjects
were randomly assigned to either the active (those who exercised while on the centrifuge)
or passive (those who rode passively) group.

Female subjects were also randomly

assigned to either group, but an effort was made to pair active and passive subjects based
on their menstrual cycles. Complete anthropomorphic data for all subjects can be found
in Table 1 of the Appendix.

Training Protocol
Artificial gravity training of subjects occurred on the NASA Ames Human
Powered Centrifuge (HPC) in building 221A at the Ames Research Center, Moffett Field,
California. Subjects trained 5 days a week (Monday thru Friday), for 3 weeks. Subjects
were assigned the same time slot everyday, for consistency in training. Experiments with
male subjects took place in April/May of 2003, while female subjects were studied in
January/February of 2004. An early schematic of the HPC is shown in Figure 3.1. Since
the time of this drawing, one of the second seats was modified for a passive rider
(ergometer removed and plate fabricated for resting feet, changes can be seen in the
photograph in Figure 3.2).
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Figure 0.1: Schematic of the human powered centrifuge at the NASA Ames Research Center.

During the week before training began, each subject was introduced to the
centrifuge facility. They were allowed to ride the HPC at moderate speeds in order to
feel comfortable with the apparatus. They were then shown the tilt table and all of the
corresponding instrumentation. Each subject was placed on the table and experienced
several tilts and lower body suctions before the study started.
When subjects arrived for a training run, 3 ECG electrodes (3M Red Dot™) were
placed on their thorax; one on the left abdomen and two on the upper chest, left and right.
ECG was acquired with the Pilot (COLIN Medial). This device can also be used to
acquire non-invasive, continuous, tonometric blood pressure, but is very sensitive to
motion artifact.

Therefore, the active rider was instrumented for continuous blood

pressure and heart rate (calculated from the blood pressure waveform) measurements via
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a plethysmographic device, which is more tolerant of motion artifact (Portapres, TNO).
The finger cuff for the Portapres was placed on one of the fingers of the left hand,
between the 1st and 2nd knuckles.
Because the passive riders were able to lie still during the training sessions, blood
pressure was acquired with the Pilot. The passive rider’s left hand was placed in a wrist
brace designed to flex the wrist in order to expose the radial artery. The tonometric
sensor was then placed approximately over the artery in order for the instrument to make
autonomic adjustments to obtain optimal signals. Acceptable signals were then verified
by the experimenter on both subjects. Analog outputs were passed through slip rings and
digitized through a National Instruments board at 200 Hz.

Data acquisition was

controlled by a program written by NASA Ames personnel in Labview on a Pentium III
class computer.
Based on subject’s heights, the seats were placed in such a fashion that the active
rider could pedal comfortable, and the passive rider could easily rest his feet flat against
the rest plate.

Both subjects had their legs bent and thighs elevated, Figure 3.2.

Sandbags of various weights were also used to balance out any difference in subject
weight. Blindfolds and headsets were secured on the subject’s heads and an alarm switch
was placed in their right hands to alert investigators in the event of an emergency.
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Figure 0.2: Photograph of 2 subjects prior to a training session. Active subject on the left, passive
subject on the right. Personal photo taken with consent from subjects.

For each training run, blood pressure, heart rate and ECG signals were verified
and alarm switches and headset communications (brand of head set?) tested for correct
operation. The active rider was then instructed to begin pedaling up to a rate of 22
rotations per minute to reach the 1 Gz level at the outer edge of the centrifuge. After
seven minutes of 1 Gz, the active rider was then instructed to increase the rate of rotation
to 35 rpm (which is equivalent to 2.5 Gz) in ten seconds. After two minutes at 2.5 Gz, the
active rider was instructed to pedal backwards as the centrifuge slowed down to 1 Gz.
Once the centrifuge reached 1 Gz, the active rider maintained the rate of rotation for
another 2 minute period. This cycle of 2 minutes at 2.5 Gz and 2 minutes at 1 Gz was
repeated 6 times for a total of 7 periods. If at any time the active subject was unable to
maintain the correct Gz level, an off-board operator assisted him/her.

A typical

acceleration profile with corresponding heart rate and blood pressure values can be seen
in Figure 3.3.
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Figure 0.3: Typical AP and HR response of an active (blue) and passive (red) subject during a
normal training session.

During these training sessions, communication was maintained between the
subjects and the person monitoring their vital signs (blood pressure and heart rate) to
insure subject safety. If the active subject’s heart rate ever reached 90% of his/her age
adjusted maximum heart rate (220 – age), then the off-board operator was asked to help
pedal. In the case of the men, this happened only rarely, and only during the first couple
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days of training. In the case of the women, this happened quite frequently—especially
during the transitions from 1.0 to 2.5 Gz.
After each training session, each subject was de-instrumented and went about
their normal daily activities. Subjects were asked to not participate in any vigorous
athletic training, although they were encouraged to maintain their already light to
moderate exercise lifestyles.

Head-Up Tilt / Lower Body Negative Pressure (HUT/LBNP) Test
In order to assess the efficacy of this training protocol, each subject’s response to
orthostatic stress was tested within 2 days before, and within 2 days after this 3 week
training period. Our provocative test was a combination of 70º head-up tilt with lower
body negative pressure (HUT/LBNP). Head-up tilt is a classic orthostatic stimulus, but
in healthy individuals it may take several hours for pre-syncopal symptoms to occur. By
adding LBNP (protocol discussed below) to this stimulus, we were usually able to reach a
pre-syncopal endpoint within 20 minutes. Care was taken to test each subject at the same
time of day both before and after training. Ambient air temperature was also controlled
to be the same for both tilts (71 ºF ± 2ºF).
Each subject arrived 30 minutes before their scheduled test time in order to place
ECG electrodes, intravenous catheter (Quick-Cath, Baxter) and consult with the medical
monitor before tilting. Once on the table, the subjects were tilted to supine, then to 70°
head-up in order to verify seat comfort. The subjects adjusted as necessary, and when
they were comfortable, they were returned to the supine position. A mercury strain gauge
(EC-4, Hokansen) was then placed around the subject’s left calf to measure changes in
calf size. Their left leg was supported by foam blocks under the ankle and thigh to
prevent any motion artifact in calf circumference measurements. At his time in the
procedure, the LBNP chamber was placed around the subject lower body, below the iliac
crest. Subjects were then further instrumented. Continuous blood pressure was measured
using a Finapres (Ohmeda) device on one of the three middle fingers of the left hand
(generally the ring finger). Laser doppler probes (PF4001, Perimed) were placed on the
left palm and forearm for skin perfusion, concentration of moving blood cells, and
velocity of blood cells. An arm cuff automated blood pressure measurement system
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(UA767, AND Medical) was placed on the upper left arm over the brachial artery for
verifying the accuracy of continuous blood pressure measurements made by the Finapres.
The subjects left arm was extended out from the body and rested in a plastic tray as
shown in Figure 3.4. The left arm was positioned in such a fashion that the finger cuff
sensor was at the same hydrostatic level as the heart in both supine and 70º head-up
positions. If necessary, a heating pad was placed on the left arm to keep the fingers warm
in order to obtain optimal blood pressure signals from the Finapres.

Figure 0.4: Fully instrumented subject on tilt table prior to HUT/LBNP test. Personal photo taken
with subject's written consent.

Leads were attached to the 11 ECG electrodes for thoracic impedance
measurements (BoMed, Cardiodynamics). Subject’s height and weight were entered into
the BoMed computer for calculation of stroke volume, cardiac output and end diastolic
volume, and all signals for verified for quality.
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At this point, an 800cc spirobag was used to calibrate fluctuations in thoracic
impedance associated with breathing. The subject’s nose was clamped, and the subject
was instructed to take 5 even expirations and inhalations into and from the 800cc
spirobag. The brachial arterial pressure was taken from the AND device and the CC was
balanced to zero before beginning the control period. At this point in the instrumentation
period, the subject has been supine on the table for 20 to 30 minutes.
The room was kept quiet, and the subject was asked to remain still and quiet for
the entire duration of the study, unless they felt any discomfort or pre-syncopal
symptoms. Ten minutes of supine control data were collected. At the end of the 10
minute control period, 23 cc’s of blood were drawn (Blood Draw #1) from the
intravenous catheter and the brachial cuff blood pressure was acquired.

The calf

circumference was again balanced, and the subject was tilted to 70° head-up. After five
minutes at 70°, the vacuum pumps were turned on and -20 mmHg of vacuum was applied
to the LBNP chamber. This was held for 3 minutes, at which point the vacuum was
increased to -30 mmHg. Twenty-three cc’s of blood were drawn (Blood Draw #2) at the
beginning of the -30 mmHg LBNP level. Vacuum was held for 3 minutes again, at which
time it was increased another 10 mmHg. This procedure was repeated up to -90 mmHg,
or until pre-syncopal conditions developed.
Once pre-syncopal symptoms developed, the vacuum was shut off and the table
was brought back to the supine position. Blood draw #3 occurred at 1 minute and 30
seconds after the tilt table was brought down from the 70° head-up position. If any of the
subjects had difficulty recovering from the stress-induced pooling, they were brought to a
slight head-down position to facilitate venous return. If the subject developed presyncopal symptoms before the -30 mmHg LBNP level, blood draw #2 was taken
immediately after the table was brought down and blood draw #3 occurred immediately
after blood draw #2 in these cases. Data during recovery were acquired for 5 minutes
after the table was brought to the supine position. At the end of recovery, the medical
monitor questioned the subject to obtain details about their pre-syncopal symptoms. Data
acquisition was set to “standby” and the subject was allowed to recovery from the
HUT/LBNP test for 15 minutes before the next test (oscillatory lower body negative
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pressure, OLBNP, see below). During this period the Finapres was turned off to reduce
external pressure to the finger and improve subject comfort.

Oscillatory Lower Body Negative Pressure (OLBNP) Test
Fifteen minutes after the end of recovery of the HUT/LBNP test, the Finapres was
turned back on for continuous blood pressure measurement, and a brachial artery pressure
measurement was recorded via the AND cuff.

The calf circumference gauge was

balanced again and the subject was exposed to -50 mmHg of sinusoidal lower body
negative pressure at 7 different frequencies, for 2 minutes each. The seven frequencies
were 0.01 Hz, 0.02 Hz, 0.04 Hz, 0.08 Hz, 0.10 Hz, 0.125 Hz and 0.15 Hz. These seven
frequencies were randomized for each subject, except for the 0.01 Hz frequency, which
was always the last frequency. Because 0.01 Hz is the slowest, and therefore most
stressful to the body, it came last in the event that the subject developed any pre-syncopal
symptoms. However pre-syncopal symptoms never occurred during any frequency of the
OLBNP test.
All data for the HUT/LBNP/OLBNP tests were digitized at 250 Hz on a 16-bit
analog to digital converter (DI-220 Parallel Port, DATAQ). Data was recorded on a
Pentium II class laptop computer. At the end of each subject’s test, data were
immediately backed up on CD, 100MB Zip disk and 3 different computer hard drives.

Data Analysis
Pre-processing
Training data were acquired as binary Labview files and HUT/LBNP/OLBNP
data was acquired using Windaq Pro acquisition software, also as binary files. The data
were the imported in to the following three analysis programs written in visual C++ by
Dr.

David

Brown

(University

of

Kentucky,

Biomedical

Engineering):

ConvertLabview.exe, ScanDataq and Browser ConvertLabview.exe and ScanDataq.exe
were used to convert the training and tilt test data, respectively, into a binary data format
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recognizable by Browser.

In Browser, heart rate and RR interval were calculated from

the ECG trace. Based on the timing of the cardiac cycle from the ECG trace, systolic,
diastolic and mean (1/3 systolic + 2/3 diastolic) blood pressure were calculated from the
arterial pressure channel. These data were then converted to floating point, 32-bit integer
binary data files for export into Matlab.
In Matlab, fread.m and fopen.m subroutines were used to import the data into a
matrix for further pre-processing.

Once in Matlab, total peripheral resistance was

calculated as mean arterial pressure divided by cardiac output. The data were then lowpass filtered with a finite impulse response filter having a cutoff frequency of 5 Hz.
Using the filtfilt.m algorithm, these data were passed through the filter forward and
backward, to minimize any phase distortions. The data were then down sampled to 10
Hz to save disk space and increase processing speed.
At this point, the data exist in a 21 column matrix with each column consisting of
a channel of data as shown in Table 2 of the Appendix. The data were further subdivided
into segments for supine control, tilt without LBNP, the tilt plus LBNP segments,
recovery and the seven different OLBNP frequencies. For control, tilt, tilt plus LBNP
and recovery, two types of segments were created. The first type was a raw segment
consisting of all the data, from the very beginning of each stress level to the very end.
The second segment type was modified to contain relatively steady-state data. This
means that any non-linear trends, such as those seen when subjects experience presyncope, were removed from the “steady-state” segments. For the OLBNP segments,
there were also two types of segments; a raw segment consisting of all the data for a
particular frequency as well as segments of 100 seconds consisting of complete cycles of
data for the 0.01, 0.02, 0.04, 0.08, 0.10 and 0.15 Hz segments. For the 0.125 Hz segment,
96 seconds of data were used so that an even number of complete cycles was available
for analysis.

Tilt Tolerance
Tilt tolerance was assessed via two methods. The first method was to determine
the total time the subject was able to withstand HUT plus any combination of LBNP
before developing pre-syncopal symptoms. In this case, time from the raw data set, in
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seconds, was used for analysis. However, because the level of vacuum applied during
LBNP is sometimes slightly variable (+/- mmHg) , and because there are also variations
(however minute) in the length of time (+/- seconds) at each LBNP level, a stress index
consisting of a combination of tilt time (in seconds) and LBNP (in mmHg) was also used.
There is evidence that -50 mmHg of LBNP causes blood pooling similar to 70° head-up
tilt (132); therefore the tilt channel was assigned a value of -50 mmHg and added to the
LBNP channel, resulting in a new indicator of orthostatic stress in pressure units. Using
this method, the initial LBNP applied to the subjects (-20 mmHg) was then given a value
approximately equal to 70 mmHg.

Mean Values
For each steady-state segment of data, mean values for each channel were
calculated.

Data were then averaged by gender and training (i.e. active or passive

subjects) group, both before and after training. Standard error of the mean was also
calculated for the same groups.

Spectral Power
Spectral power estimations were performed using the power spectral density (psd)
algorithm in Matlab. This algorithm utilizes Welch’s averaged periodogram method. For
HUT/LBNP data, this method works by taking the first 1024 points of data for each
variable, removing the mean and any linear trend from this segment and then passing
these data through a 1024 point Hanning window. The magnitude of the FFT for this
segment is calculated and stored. The program then moves 50% of the segment (512
points) into the data, and does the same thing to the next 1024 points. The magnitudesquared of these two FFT segments are averaged to form the new output. The algorithm
continues this process until it reaches the end of the data. If at any time there are less
than 1024 points, the data is zero padded to length 1024. The output of the PSD
algorithm was then integrated over the low frequency (LF, 0.04 – 0.15 Hz) and high
frequency (HF, 0.15 – 0.40 Hz) regions.
For OLBNP data, first harmonic amplitudes and phases of the fast fourier
transform (FFT) are reported. For all frequencies other than 0.125 Hz, complete cycles
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could be obtained with 100 second (1000 pt) segments and for 0.125 Hz, 960 points of
data were used to obtain 8 complete cycles at this frequency. Phase outputs are reported
with respect to OLBNP input.

Blood Assays
Catecholamine assays were performed in Dr. Michael Ziegler’s lab at the
University of California, San Diego using a radioeznymatic technique (81).

Other

vasoactive hormones were analyzed by Dr. Helmut Hinghofer at the University of Graz,
Austria using commercially available kits.

Baroreflex Analysis
Sensitivity of the cardiac baroreflex (BRS) as well as number of cardiac
barosequences (NNS, normalized by number of heart beats) were assessed using selfwritten script files in Matlab. Baroreflex activity (BA, sensitivity and normalized number
of sequences) was calculated for all HUT/LBNP segments as well as for data early and
late in HPC training. For training data, the BA numbers reported are averaged from two
days selected within the first four days of training and within the last three days of
training. On each day of training, 7 segments at 2.5 Gz and 8 segments at 1.0 Gz are
analyzed.
For each segment of data, the ECG trace is used to calculate beat-to-beat RR
Interval (RRI) and systolic blood pressure (SBP). Each SBP sequence is analyzed for a
sequence of three or more beats increasing or decreasing in succession, with each change
between beats being 1 mmHg or more. During these sequences, the RRI is examined (on
a one beat delayed basis) for changes in the same direction as the SBP changes, with each
change being 8 ms or more. Eight ms is chosen because ECG was digitized at 250 Hz,
so each R-wave can only be resolved within 4 ms. This leads to a possible 8 ms error
when comparing 2 beats, hence the 8 ms criteria for changes in RRI.
Each barosequence is plotted as RRI vs. SBP, and the slope of the best fit line
between the points is calculated from Equation 1 below as an index of BRS. The NNS is
calculated as the number of barosequences (n) divided by the total number of heart beats
in each analyzed segment of data.
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BRS = Slope =

NNS =

n(∑ RRI * SBP ) − (∑ RRI )(∑ SBP )

(

)

n ∑ RRI 2 − (∑ RRI )

2

n
Number _ of _ Heart _ Beats

Equation 1

Equation 2

Statistics
Four factor analysis of variance (ANOVA) was used to calculate significance
between all groups using SAS (The SAS Institute) software. Between group variables
were gender (male vs. female) and training group (active vs. passive) and within group
variables were test day (before vs. after training) and stress level (control/tilt/LBNP level
or in the case of OLBNP, the LBNP input frequency).

Fischer’s least significant

difference method was used, therefore significance was accepted for p < 0.05. An
example of SAS code used is presented in Appendix B.
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Chapter 4: Results
A subject’s typical response to a HUT/LNBP test is shown below in Figure 4.1.
All other individual responses are shown in Appendix A.

Figure 0.1: Typical AP, HR, SV, CO, TPR and CC responses of a presyncopal subject to 70º HUT
combined with progressive levels of LBNP.

At the onset of tilt, the calf circumference starts to rise, indicative of fluid
accumulating in the lower leg. In response to this shift of fluid, heart rate and vascular
resistance increases to maintain venous return and blood pressure. In the case of this
subject, this is seen as an increase in blood pressure. Stroke volume decreases as the
heart rate increases, as there is less filling time. These changes continue as lower body
negative pressure is applied. This particular subject withstood -60 mmHg of LBNP
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before developing classical vasovagal syncope, indicated by decrease in blood pressure,
heart rate and vascular resistance.
There were varying degrees of tolerance among the subjects, and only a very few
were able to endure the stress long enough to make to the higher vacuum levels (-50 and 60 mmHg). The only segments that all subjects had in common were the 10 minute
supine control period and the 5 minute HUT period before any LBNP was applied.
Although one subject experienced presyncopal symptoms before the vacuum was
applied, most subjects were able to endure the passive HUT. After application of LBNP,
tolerance ranged from a few seconds at the -20 mmHg level to some subjects enduring
several minutes of -60 mmHg. Because of this difference in how each subject endured
LBNP, each subject’s response during the last four minutes (LST4) of stress, regardless
of LBNP level, was also assessed. This LST4 value was assessed before presyncopal
symptoms develop. For the above reasons data are presented for 5 different experimental
levels (referred to in the following discussion as “segments”): control, tilt (w/o LBNP), 20 mmHg LBNP, LST4 and recovery.

Effects of Artificial Gravity on HUT/LNBP Tolerance
Artificial gravity training increased HUT/LNBP tolerance in the group of 26
subjects by 13% (t-test, p < 0.02, Figure 4.2). As shown in Figure 4.2 below, men lasted
longer during the HUT/LNBP test than did women (p < 0.01).

When examined

separately, the group of active subjects (men and women combined) were improved by
training (p < 0.05) as were the men (active and passive combined, p < 0.04). Passive
women were not improved by training. When using the “stress index” (Method two) no
differences were indicated from those already obtained from the standard “time of tilt”
analysis.
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Tilt Tolerance

16

BEFORE TRAINING

Tolerance Time (minutes)

AFTER TRAINING

11

6
ACTIVE

PASSIVE

ACTIVE

MEN

PASSIVE

WOMEN

Figure 0.2: Tilt tolerance time shown for men (left, 7 active, 7 passive) and women (right, 7 active, 5
passive), before and after artificial gravity training.
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Mean Values for HUT/LNBP Test Before and After AG Training
Arterial Pressure
Mean values of arterial pressure are shown in Figure 4.3. When pooling all data
to make segment-only comparisons, AP was not different from segment to segment (i.e.,
there were no main segment effects in the ANOVA).

Figure 0.3: Blood pressure by gender and training group, before and after AG training.

While there was no overall difference in blood pressure during different levels of
orthostatic stress when pooling both men’s and women’s data, separating gender did
elucidate some different responses to orthostatic stress. Compared to supine control, men
increased AP during HUT and -20 mmHg LBNP while women decreased AP during -20
mmHg LBNP, Figure 4.4. Men had higher AP (99.8 ± 1.1 mmHg) than women (89.7 ±
1.6 mmHg), Figure 4.4.
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Figure 0.4: Gender by segment difference in blood pressure.

Artificial gravity training decreased blood pressure in all subjects, Figure 4.5.

Figure 0.5: Mean AP (for all segments of the HUT/LNBP test) before and after AG training.

Heart Rate
In response to increasing orthostatic stress, heart rate increased as would be
expected. Heart rate increased from control to HUT, HUT to -20 mmHg LBNP, and 20mmHg LBNP to LST4 before returning to control levels during recovery, Figure 4.6.
There was no overall effect of training, although there was a training by segment
interaction – heart rate was higher during the last 4 minutes of stress after training (98.4 ±
4.2 bpm before, 104.5 ± 3.3 bpm after training).
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Figure 0.6: Heart rate by gender and training group, before and after AG training.

Regardless of test day (i.e. regardless of before or after training), women had higher HR
during -20 mmHg LBNP than did men, Figure 4.7.

Figure 0.7: Gender by segment difference in heart rate. *Significant difference between gender.

Stroke Volume
Mean stroke volume decreased with HUT and -20 mmHg LBNP. Statistically,
the mean value of SV during LST4 was not different from -20 mmHg LBNP, although it
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was significantly lower than control and recovery. The recovery value of SV was higher
than the control value, Figure 4.8.

Figure 0.8: Stroke volume by gender and training group, before and after AG training.

Men had a higher stroke volume than did women (Figure 4.9a) and training increased
overall stroke volume (Figure 4.9b).

Figure 0.9: (a) Gender difference in stroke volume, (b) AG training effect on stroke volume.

Cardiac Output
Cardiac output initially decreased with the onset of HUT, but then was maintained
as the test progressed, reaching control values again during supine recovery, Figure 4.10.
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Figure 0.10: Cardiac output by gender and training group, before and after AG training.

Men appear to have had a higher cardiac output than women (Figure 4.11a) but this was
only at a marginally significant level (p = 0.068). When examined as a function of test
day, men had a higher cardiac output after training than before training, and this after
training value was higher than women’s CO on both experimental days (Figure 4.11b).

Figure 0.11: (a) Gender difference in cardiac output, (b) gender by test day effect on cardiac output.

End Diastolic Volume
Similar to stroke volume, end diastolic volume decreased at the onset of tilt, and
continued to decrease with the onset of LBNP. Also similar to stroke volume, the LST4
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value was not different from the -20 mmHg LBNP value and the EDV recovered to a
level higher than control, Figure 4.12.

Figure 0.12: End diastolic volume by gender and training group, before and after AG training.

Men had higher EDV than women (Figure 4.13a). There was not a main training effect
in the ANOVA, but there was a training-induced increase in EDV during control and
recovery (Figure 4.13b).

*
*

Figure 0.13: (a) Gender difference in EDV, (2) day by segment effect on EDV. *Significant effect of
training.
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Total Peripheral Resistance
Total peripheral resistance increased in response to HUT (Figure 4.14). TPR was
maintained when LBNP was started, but was significantly lower than the HUT value
during the last 4 minutes of stress. TPR recovered to the control value during recovery.

Figure 0.14: TPR means by stress level.

Figure 0.15: Total peripheral resistance by gender and training group, before and after AG training.

ANOVA results indicate that artificial gravity training decreased TPR, but this can be
misleading, as Figure 4.15 (above) shows that TPR isn’t increased in active women after
training. This was corroborated by a protocol by gender interaction effect, indicating that
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training decreased TPR in active men, passive men and women, but not in active women.
Notice, however, that active women have a lower TPR before any artificial gravity
training, and their before/after values look similar to the after values of the other 3
groups.

Calf Circumference
Due to the time-dependant nature of calf circumference during an orthostatic
stress, absolute values of CC had to be normalized by time of stress, Figure 4.16.

Figure 0.16: Various calf circumference slopes measured.

CCI refers to the initial slope at the onset of tilt, from point one to two on Figure 4.16.
This refers to the initial shift of fluid from the upper body to the lower legs, and usually
lasts about 15 to 20 seconds before the slope decreases significantly. CCT is the value of
CC at the end of HUT/LBNP normalized by the time of stress, or the slope of the line
from point 1 to 3., This represents the total fluid shift during the orthostatic stress. CCR is
the value that the CC recovers to at the end of recovery, normalized by the amount of
time up to that point, given by the slope of the line from point one to four. This slope
represents the amount of fluid left in the lower leg several minutes after the end of the
orthostatic test. Point four is the lowest value that CC reaches during the recovery
period, which usually occurs near the end of the recovery period; however, motion
artifact or drift in the signal sometimes required this value to be sampled a couple
minutes before the end of the five minute recovery period. There was no change in CCI
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or CCT after training, nor were there any differences between gender or training groups.
On the other hand, CCR was increased after training (main effect), especially in the active
subjects (interaction effect), Figure 4.17. Both active men and active women increased
CCR after training, while passive women decreased CCR after training (marginally
significant, p = 0.07).

Figure 0.17: CCR by gender and training group.
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Spectral Power Analysis of Responses to HUT/LNBP Test Before and
After Artificial Gravity Training
Power spectrum analysis of arterial pressure and RR interval data has been used
as a non-invasive index of sympathetic (low frequency, LF, 0.04 – 0.15 Hz) and
parasympathetic (high frequency, HF, 0.04 – 0.15 Hz) nervous system control (1, 41, 98).
In addition to analyzing the power spectrum of AP and HR, power spectrum of SV, EDV,
CO and TPR was estimated to determine if artificial gravity training had any effect on
these indices.

Arterial Pressure
Head-up tilt and LBNP increased low-frequency spectral power of blood pressure,
Figure 4.18. Spectral power during LST4 was higher than all segments other than -20
mmHg LBNP.

Figure 0.18: Low frequency AP spectral power averaged for all subjects.

Low frequency AP spectral power was not affected by training, and there were no gender
or training protocol differences. High frequency spectral power was increased by stress
as well, but only during -20 mmHg and LST; tilt-induced HF spectral power was not
significantly greater than control, Figure 4.19.
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Figure 0.19: High frequency spectral power averaged for all subjects.

High frequency spectral power in men was lower than in women, Figure 4.20a. Women
decreased high frequency power as a result of training (p = 0.02) while men tended to
increase power with training (NS), Figure 4.20b.

Figure 0.20: (a) High frequency AP spectral power by gender and (b) by gender and day.

Heart Rate
Orthostatic stress increased low frequency spectral power of heart rate (HUT/20mmHg LBNP/LST4 all higher than control and recovery, Figure 4.21a). Artificial
gravity training increased low frequency spectral power at -20mmHg and LST4, Figure
4.21b.
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*

*

Figure 0.21: (a) Low frequency HR spectral power averaged across all subjects and (b) separated by
day. *Significant effect of training.

Orthostatic stress had the opposite effect on high frequency HR spectral power, Figure
4.22a. Spectral power at -20mmHg LBNP and LST4 was significantly lower than in
control and recovery. There was a marginally significant difference in gender (women >
men, p = 0.07), Figure 4.22b.

*

*

*

*

Figure 0.22: High frequency HR spectral power averaged across all subjects and (b) separated by
gender. *Significant difference between gender.

Stroke Volume
Low frequency spectral power of stroke volume decreased during HUT, but was
independent of orthostatic stress level, Figure 4.23a. Both supine values were higher than
tilt, -20 mmHg LBNP and LST4 (which are not statistically different than each other).
An unexpected result was that LF spectral power was higher in recovery than in control.
This effect was compounded after training, Figure 4.23b.
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Figure 0.23: (a) Low frequency SV spectral power across all subjects and (b) separated by day.

High frequency spectral power of stroke volume was not affected by orthostatic stress
level. There was no main gender effect, although men did show higher power after
training than before, Figure 4.24.

Figure 0.24: High frequency SV spectral power for men and women, before and after training.

Cardiac Output
Low frequency cardiac output spectral power tended to be lower during
orthostatic stress than in control, but this effect was only significantly different between
control and -20 mmHg LBNP, Figure 4.25. Similar to stroke volume, LF spectral power
was elevated during recovery.
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Figure 0.25: Low frequency CO spectral power averaged across all subjects.

High frequency spectral power of cardiac output was decreased by HUT alone, Figure
4.26. Application of -20 mmHg LBNP increased HF CO spectral power (p = 0.06) and
CO power remained elevated during the last 4 minutes of stress (p < 0.05).

Figure 0.26: High frequency CO spectral power averaged across all subjects.

End Diastolic Volume
End diastolic volume LF spectral power behaved in a fashion similar to cardiac
output, Figure 4.27. There was no significant difference between control and HUT, but
power at -20 mmHg LBNP was statistically lower than control.

Power difference

between control and LST4 was only marginally significant (p = 0.06). Also like cardiac
output LF power, recovery power was significantly greater than all other stress levels,
including supine control. There were no significant effects in high frequency EDV
spectral power.
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Figure 0.27: Low frequency EDV spectral power averaged across all subjects.

Total Peripheral Resistance
Orthostatic stress increased low frequency TPR spectral power, Figure 4.28.
Control and recovery power were both significantly lower than power during all levels of
stress. Power was not different during tilt, -20 mmHg LBNP and LST4.

Figure 0.28: Low frequency TPR spectral power averaged across all subjects.

There were no main gender or training day effects, though there was an interaction effect
between gender/day/stress level, Figure 4.29. Women’s low frequency TPR power in tilt
and LST4 was significantly higher than the power of all other groups (women before,
men before, men after) during these two stress levels.
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Figure 0.29: Low frequency TPR spectral power for men and women, before and after training.

High frequency spectral power of TPR was also elevated during orthostatic stress, Figure
4.30a. Power during Tilt, -20 mmHg and LST4 was higher than power during control
and recovery, with LST4 HF power being higher than all levels. Women had higher HF
TPR power than did men, Figure 4.30b. There was no effect of training.

Figure 0.30: (a) High frequency spectral power averaged across all subjects and (b) by gender.
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Responses to OLBNP Test Before and After Artificial Gravity Training

Arterial Pressure
Arterial pressure amplitude response tended to decrease as input frequency
increases, Figure 4.31a. Amplitudes at 0.10 Hz, 0.125 Hz and 0.15 Hz were lower than at
0.01 Hz. At 0.04 Hz; the amplitude response was significantly higher than the response
at all frequencies except for 0.01 Hz. There were no other gender, protocol or day
effects, although there was a gender by protocol by segment effect; active women had a
higher amplitude response than passive women at 0.04 Hz, and higher than active men at
0.04 Hz and 0.08 Hz. Passive women had a higher amplitude response at 0.01 Hz than
did passive men, Figure 4.31b.

Figure 0.31: (a) AP amplitude response averaged across all subject and (b) by gender and training
group.

In general, AP phase response did not vary with input frequency, except at 0.08
Hz, Figure 4.32. The AP phase response at this frequency was significantly higher than
the response at all other input frequencies.
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Figure 0.32: AP phase lags averaged across subjects.

Heart Rate
Heart rate amplitude response was significantly higher at the two lowest input
frequencies, 0.01 Hz and 0.02 Hz than at all other input frequencies, Figure 4.33a. There
was no change in amplitude response from 0.04 Hz to 0.15 Hz.

The only gender

difference occurred at 0.01 Hz, where women had a higher amplitude response than did
men, Figure 4.33b.

*

Figure 0.33: (a) HR amplitudes averaged across all subjects and (b) by gender.
difference between gender.

*Significant

There was no overall effect of artificial gravity training, although there were a few
training day interactions between protocol and segments, Figure 4.34 below. At the
slowest input frequency, 0.01 Hz, active training decreased HR amplitude.

This

amplitude response (at 0.01 Hz) for the active group after training was lower than the
responses for the passive group on both test days. At the second slowest input frequency,
0.02 Hz, passive training increased HR amplitude.
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Figure 0.34: HR amplitude for actives (a) and passives (b), before and after training.

Increased input frequency was associated with a slower response, Figure 4.35.
There was no difference between the phase lags at 0.01 to 0.04 Hz; however, the phase
lag at these three frequencies were significantly lower than the lag at each of the input
frequencies from 0.08 to 0.15 Hz. Similar to the lag at the three lowest frequencies, the
lag at the 3 highest frequencies were not different from each other.

Figure 0.35: HR phase lags averaged across all subjects.

While there was no overall gender difference in the phase response, women
responded differently than men at higher input frequencies, Figure 4.36 below. Women
significantly increased phase lags from 0.04 Hz to 0.08 Hz, and nearly significantly (p =
0.08) increased phase lags from 0.08 to 0.10 Hz.

Men did not have these slower

responses from 0.04 to 0.08 Hz (p=0.42) or from 0.08 to 0.10 Hz (p=0.59). Additionally,
women’s phase lags at 0.125 and 0.15 Hz was higher than at 0.08 Hz, while there was no
difference in phase for men from 0.08 to 0.15 Hz.
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*

*

*

Figure 0.36: HR phase lags by gender. *Significant gender difference.

Stroke Volume
Stroke volume amplitude during the slowest input frequency was higher than the
response at every other input frequency, Figure 4.37. Stroke volume amplitude response
at 0.02 Hz was higher than the response at 0.08, 0.125 and 0.15 Hz.

Figure 0.37: SV amplitudes averaged across all subjects.

There was no difference between gender, but there was a training effect; stroke
volume amplitude response was higher in passive subjects after training than before
training, Figure 4.38. There was no difference in the active subjects.
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Figure 0.38: SV amplitudes for active (a) and passive (b) groups, before and after AG training.

In general, phase lag increased as input frequency increased, Figure 4.39a. Phase
at 0.01 Hz was lower than at 0.04, 0.10, 0.125 and 0.15 Hz. Phase lag increased from
0.10 to 0.125 Hz and from 0.125 to 0.15 Hz. At 0.04 Hz, phase lag was higher than at
0.01, 0.02 and 0.08 Hz. Men had significantly lower phase lags than did women, Figure
4.39b.

Figure 0.39: (a) SV phase lags averaged across all subjects and (b) by gender.

There was not an overall protocol or training effect, although there was an
interaction term between training protocol and training day by input frequency (3 way
interaction), Figure 4.40. The phase lag appears to reach a local maximum at 0.04 Hz in
active subjects before and after training, as well as passive subjects before training;
however, the phase response at 0.04 Hz after passive training is lower than those from
these 3 groups.
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Figure 0.40: SV phase lags for active (a) and passive (b) subjects, before and after AG training.

Cardiac Output
Cardiac output amplitudes were not affected by input frequency, Figure 4.41.
There were no differences in gender, training protocol or training day.

Figure 0.41: CO amplitudes averaged across all subjects.

Phase lag tended to increase with increasing LBNP input frequency, Figure 4.42a.
Phase lag at 0.01 Hz was lower than at all other frequencies, and except for the decrease
from 0.04 to 0.08 Hz, phase lag increased with each increase in input frequency from
0.02 to 0.15 Hz.
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Figure 0.42: (a) CO phase lags averaged across all subjects and (b) separated by gender.

There was no phase difference between training groups, and no over all gender or
training day effect, although there was a difference in the way men and women
responded to various input frequencies, Figure 4.42b. Men increased phase lag from the
slowest input to 0.02 Hz, while women’s response was not different for the two slowest
frequencies. This trend was similar at the two highest frequencies; women showed no
difference, while men increased phase lag from 0.125 to 0.15 Hz.

End Diastolic Volume
The amplitude of the EDV response was higher for the 0.01 Hz input than for the
next two (0.02 and 0.04 Hz) input frequencies, as well as the two fastest (0.125 and 0.15
Hz) frequencies, Figure 4.43. The amplitude response at 0.04 Hz was lower than that at
0.10 Hz.

Figure 0.43: EDV amplitudes averaged across all subjects.
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There was no difference in the EDV phase response to the 4 slowest input
frequencies, although the phase at these 4 frequencies was significantly lower than each
of the phase responses during the fastest three frequencies, Figure 4.44. The response of
EDV to the LBNP input went farther out of phase for each increase in input frequency
from 0.08 to 0.15 Hz (increase from 0.10 to 0.125 only marginally significant, p = 0.07).
There were no differences in the EDV amplitude or phase response between gender,
training group or tilt day.

Figure 0.44: EDV phase lags averaged across all subjects.

Total Peripheral Resistance
The TPR amplitude response was independent of input frequency, but only
marginally so (p = 0.0579, Figure 4.45a). There was no training protocol effect, or effect
of tilt day, although there was a difference in gender; women had a higher TPR amplitude
response than men, Figure 4.45b.

Figure 0.45: (a) TPR amplitudes averaged across all subjects and (b) separated by gender.
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Although the TPR amplitude response was independent of input frequency, TPR phase
lag increased with each increase in LBNP input frequency, Figure 4.46.

Figure 0.46: TPR phase lags averaged across all subjects.

There was no overall gender effect, training protocol or tilt day effect, although
there was a protocol by day effect; active men had lower TPR phase lags after training,
Figure 4.47a. Active men’s phase lag after training was also lower than the phase lag of
active women on both days (Figure 4.47c) and passive women on both days (Figure
4.47d). It was only marginally significantly lower than passive men after training (Figure
4.47b, p = 0.071).
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Figure 0.47: TPR phase lags, before and after training for active men (a, top left), passive men (b, top
right), active women (c, bottom left) and passive women (d, bottom right).

Calf Circumference
Calf circumference amplitude decreased with increasing input frequency from
0.01 Hz to 0.08 Hz, but did not change from 0.08 Hz to 0.15 Hz, Figure 4.48a. Women
had a lower amplitude response at 0.01 Hz than did men, Figure 4.48b. Women did not
significantly decrease amplitude response from 0.01 to 0.02 Hz as did men, nor did they
have any difference in amplitude response from 0.08 Hz to 0.15 Hz; men’s amplitude
response at 0.125 Hz was lower than at 0.08 Hz, and nearly significantly lower at 0.15 Hz
(compared to 0.08 Hz, p = 0.065).
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*

Figure 0.48: (a) CC amplitudes averaged across all subjects and (b) separated by gender.
*Significant gender difference.

In contrast to the decreasing amplitude response of CC, phase lag increased with
faster input frequencies from 0.02 Hz to 0.08 Hz, Figure 4.49. There was no phase
difference from 0.08 Hz to 0.15 Hz.

Figure 0.49: CC phase lags averaged across all subjects.

Active training tended to decrease phase lag (p = 0.09) while passive training appeared to
have the opposite effect (NS, p = 0.25), Figure 4.50. There was a significant effect of
training (decreased lag) in the active subjects at input frequencies of 0.10, 0.125 and 0.15
Hz, Figure 4.50a. Additionally, the phase response of active subjects after training was
nearly independent of input frequency; other than the responses at 0.04 and 0.08 Hz,
which were higher than at 0.01 Hz, there were no other statistical differences between
any frequencies. The passive subjects, however, showed considerable changes with
increasing input frequency after training, Figure 4.50b. Not only did the phase lag
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increase from 0.01 to 0.02 Hz, and 0.02 to 0.04 Hz, the phase lags at 0.01 and 0.02 Hz
were lower than at all other frequencies, unlike the active subjects after training.

*

*

*

Figure 0.50: CC phase lags for (a) active and (b) passive subjects, before and after training.
*Significant effect of training.
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Baroreflex Analysis
Training
Baroreflex analysis was performed on only passive subjects during training. The
data from the 1 Gz and 2.5 Gz segments were compared to data from supine control and
70º HUT for these same subjects. For both BRS and NNS, supine control and 1.0 Gz
rotation were not significantly different from each other, nor were 2.5 Gz rotation and 70º
HUT. However, both supine control and 1.0 Gz rotation were significantly different from
both 2.5 Gz rotation and 70º HUT, Figure 4.51. There were no differences between
gender, and no effect of training.

Figure 0.51: (a) Baroreflex sensitivity averaged across all passive subjects during artificial gravity
training. (b) Normalized number of baroreflex sequences averaged across all passive subjects during
artificial gravity training.

HUT/LBNP
The sensitivity of the baroreflex decreased from control to HUT, but did not
change from HUT to -20 mmHg LBNP, nor from -20 mmHg LBNP to LST4, Figure
4.52a.

The recovery value of BRS was higher than the other 4 segments.

The

normalized number of baroreflex sequences increased from control to HUT, then
decreased from HUT to -20 mmHg LBNP, Figure 4.52b. The number of sequences
during HUT was significantly higher than in all other segments.
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Figure 0.52: (a) Baroreflex sensitivity averaged across all subjects during HUT/LBNP test. (b)
Normalized number of baroreflex sequences averaged across all subjects during HUT/LBNP test.

There were no differences between gender, training protocol, or as a result of training,
although there was an interaction between protocol and day. Passive subjects had a lower
number of sequences after training, Figure 4.53. Passive subjects before training did not
have the decrease in sequences from HUT to -20 mmHg and LST4 that the other three
groups (active before, active after, passive after) exhibited.

Figure 0.53: Normalized number of baroreflex sequences averaged for (a) active and (b) passive
subjects, before and after training.
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Blood Assay Results
Norepinephrine
Norepinephrine values increased with orthostatic stress, and then decreased
during recovery; however, the recovery values were still higher than control values,
Figure 4.54a.

When compared by gender, men did not have the decrease in

norepinephrine from -30 mmHg LBNP to recovery that women exhibited.

Figure 0.54: (a) Norepinephrine averaged across all subjects and (b) separated by gender.

Women had lower norepinephrine in recovery (compared to -30 mmHg LBNP) both
before and after training, Figure 4.55. While not significant, men appeared to increase
norepinephrine in recovery after training (men recovery, before vs. after, p = 0.077).

Figure 0.55: Norepinephrine before and after training by gender.
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Epinephrine
Female epinephrine data were unavailable.

Men increased epinephrine from

control to HUT (plus -30 mmHg LBNP) and recovery, although there were no effects of
training or training protocol, Figure 4.56.

Figure 0.56: Epinephrine from men, before and after training.

Aldosterone
Aldosterone was higher in the third blood draw (at the time of pre-syncope) than
during the first two blood draws, Figure 4.57. There were no differences in gender, or
effects of training or training protocol.

Figure 0.57: Aldosterone averaged across all subjects.
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Plasma Renin Activity
Similar to aldosterone, plasma renin activity (PRA) was higher at pre-syncope
than during control or HUT (plus -30 mmHg LBNP), Figure 4.58. There were no
differences in gender, or effects of training or training protocol.

Figure 0.58: Plasma renin activity averaged across all subjects.

Total Protein
Total protein (TP) increased from control to HUT (plus -30 mmHg LBNP) to presyncope, Figure 4.59a. There were no effects of training or training protocol, although
women did not increase TP from HUT (plus -30 mmHg LBNP) to pre-syncope, Figure
4.59b.

Figure 0.59: (a) Total protein averaged across all subjects, and (b) separated by gender.
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Arginine Vasopressin
Arginine vasopressin (AVP) increased from blood draws #1 through #3 in men,
but there were no changes in AVP in women with increasing orthostatic stress, Figure
4.60a. After training, men had the same control value of AVP, but did not increase AVP
release with increasing orthostatic stress, Figure 4.60b.

*
*

Figure 0.60: Arginine vasopressin for (a) men and women and (b) men, before and after training.
*Significant effect of training.
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Chapter 5: Discussion
Responses to HUT/LBNP
Orthostatic Tolerance
This research has shown that three weeks of intermittent artificial gravity training
of 35 minutes a day is capable of improving orthostatic tolerance to a combination
HUT/LBNP test for normal, ambulatory human subjects. Exercise accentuates artificial
gravity training, evidenced by increased tolerance in both male and female active
subjects, Figure 4.2. While this is the first study known to increase tolerance in normal,
ambulatory subjects, exercise combined with AG training has been shown in the past to
ameliorate the effects of simulated microgravity via dry water immersion (126, 127).
Those studies used Gz exposures ranging from 0.8 to 2.0 Gz, from 40 minutes to a couple
hours a day. Results from these water immersion studies indicate that artificial gravity
training was optimal when exercise was coupled with centrifugation from 0.8 to 1.6 Gz,
for 2 hours a day. Because our ambulatory subjects, especially those who exercised,
showed improved tolerance after only 35 minutes a day of training, it is logical to
hypothesize that this protocol would maintain or improve tolerance for subjects who have
adapted to microgravity.
While there was no statistically significant improvement in our passive subjects,
nor a significant difference between passive men and women, it appeared that there was a
trend for artificial gravity training to improve tolerance in passive men, while slightly
reducing tolerance in passive women, Figure 4.2. Other studies have shown improved
cardiovascular function with artificial gravity alone (without exercise), but these studies
did not test the effects of centrifugation on tolerance to an orthostatic stress (26, 75).
Iwasaki et al reported two, 30-minute sessions a day, for four days, of short arm
centrifugation prevented HDBR deconditioning effects on plasma volume and baroreflex
function, but was unsuccessful in preventing loss of exercise capacity (75). These results,
along with our findings, suggest that exercise is an important part of the artificial gravity
countermeasure to orthostatic intolerance.
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Although we were unable to measure work intensity via MV02 during our HPC
training protocol, heart rate responses of active subjects during the ramp-up from 1 Gz to
2.5 Gz reached 185 ± 5 bpm which, along with the subject’s assessment, indicated that
these ramp-up periods required high intensity work.

Therefore the active subjects

received artificial gravity training via centrifugation, acute, high intensity exercise during
Gz level increments, and moderate endurance exercise (average HR of 146 ± 6 bpm
during the 2.5 Gz level). Acute, high intensity exercise alone near the end of a simulated
microgravity study has been suggested to be effective in preventing the deconditioning
effects of simulated microgravity and orthostatic intolerance (28, 29, 39). However,
when used as a countermeasure during actual spaceflight, the response to the post-flight,
standard stand test was no different in the exercise versus the control group (94). The
addition of artificial gravity while exercising could help to prevent orthostatic intolerance
in astronauts returning from space, but at present the technique has not been tried.
While the active female group improved tolerance after training, they were
statistically less tolerant to HUT/LBNP than their male counterparts. This was true of the
passive group as well—all men were more tolerant to HUT/LBNP than were women.
This dichotomy was expected and has been well documented (23, 43, 45, 49, 93, 136,
139). This decreased tolerance to HUT/LBNP is most likely caused by increased pooling
in the pelvic region in women (93, 139). It is encouraging that the active women in this
protocol improved their tolerance to HUT/LBNP, and possible mechanisms for this
improvement are discussed below.

Hemodynamic Responses
The hemodynamic responses to HUT were as expected; heart rate and vascular
resistance increased concomitantly with a decrease in stroke volume, cardiac output and
end diastolic volume, resulting in only minor changes in arterial pressure. It should be
noted that the absolute values of cardiac output reported in this study are higher than
values previously reported, although changes from baseline are within normal ranges.
Men responded to HUT and -20 mmHg LBNP by increasing blood pressure,
while women decreased blood pressure in response to -20 mmHg LBNP. This drop in
blood pressure when the vacuum was activated could be indicative of increased pooling
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in the splanchnic regions, which lie partially inside the vacuum chamber. Women also
had a higher heart rate response to -20 mmHg LBNP than did men, although their supine
control values were similar, indicating that their cardiovascular systems were more
stressed at this early point in the HUT/LBNP test than were men’s. This increase in heart
rate without any changes in vascular resistance, suggests that women may respond to
stress through vagal, rather than sympathetic mechanisms (23, 41, 49).
Artificial gravity training decreased arterial pressure, total peripheral resistance,
and increased stroke volume for all subjects, and increased cardiac output in men. Men
had a higher stroke volume and cardiac output than did women, although these gender
differences disappear when values are normalized by body surface area.

Increased

cardiac output and stroke volume could be the result of increased circulating blood
volume. While this variable was not measured in our study, other investigators have
reported increased blood volume with high Gz training (26) and plasma volume
restoration during HDBR with AG training (75). The decrease in mean TPR after
training could have improved orthostatic tolerance via two mechanisms. First, a lower
vascular resistance could indicate a greater “vasoconstrictor reserve,” or the degree to
which a subject can increase TPR to maintain blood pressure (51, 108). Results from this
study (Figure 4.15) however, yielded diminished TPR during orthostatic stress, including
at pre-syncope. If these subjects increase vasoconstrictor reserve capacity, they did not
utilize it by increasing TPR near pre-syncope after training.

Secondly, decreased

arteriole resistance coupled with enhanced venomotor tone (not measured) could increase
venous return which would increase cardiac output through increased stroke volume.
Improved vascular function becomes very important when dealing with post-spaceflight
orthostatic intolerance because one of the underlying mechanisms of this intolerance is
diminished TPR response to tilt (7, 91, 92, 136).
Overall decreased TPR after training could partly be due to larger leg muscles
(more vascular beds) after training, especially in the active subjects. Exercise training is
well known to increase muscle size (102, 120, 121); in fact, in a nearly identical exercise
with AG protocol, magnetic resonance imaging of the quadriceps showed significant
volume (4% to 6% each, p < 0.0001) increase in all four muscles (57). We report a larger
calf recovery volume after training in active subjects (Figure 4.17), with no change in
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passive men and a tendency for passive women to decrease CCR after training (p = 0.07).
This indicated that more fluid remained in the calf during recovery after training, even
though the increase in calf size during maximal stress was not different (no increase in
CCT). This suggests that the active subjects had larger calf sizes before the onset of
HUT/LBNP after training, and the same relative increase in CC (no change in CCT)
yielded a larger pooling of fluid in the calf (larger CCR).
Increased resting vasodilation after training could be the result of increased shearmediated nitric oxide (NO) activity. Exercise training has been shown to increase NO
function, a result of increased flow in the legs due to metabolic demands of exercising
muscle (56). It is probable that our centrifuge training protocol accentuates this effect by
increasing fluid shifts to the lower legs. However, this shifting of fluid to the legs via
short arm centrifugation has been shown to reduce cutaneous blood flow in the legs, most
likely through peripheral vasoconstriction caused by unloading of baroreceptors (132).
Therefore, during training, a local autacoid-mediated dilation could counteract extrinsic
sympathetically-driven constriction. It is possible that the magnitude of these opposing
mechanisms during hypergravity helped to improve tolerance to orthostatic stress.
The above argument is not as persuasive when considering female subjects.
Active women did have a larger CCR, however, they did not show a decrease in TPR after
training, Figure 4.15. It is important to note that active women already had low mean
TPR values before training that were already as low as those reached by the other three
groups after training (active women before < passive women before and after, p =
0.0175, and not significantly different from both male groups after training). These
subjects may have had lower TPR before training due to 1) circulating estrogen (129,
143) (this does not explain the difference between female groups) and 2) even though an
effort was made to randomize these female subjects, at baseline the active women were
more athletic than their passive counterparts.

Neurohumoral Responses
The neurohumoral responses to orthostatic stress reported in this study are similar
to those reported previously (77). As expected, norepinephrine and epinephrine were
enhanced during the second blood draw (during HUT with -30 mmHg LBNP).

68

Aldosterone and PRA were not significantly enhanced until the 3rd blood draw (at the
point of pre-syncope).
Total protein concentrations increased with increasing orthostatic stress, which is
indicative of fluid filtration out of the vascular system. Women did not have a significant
increase in TP concentration from blood draw #2 to #3. This is most likely due to the
small amount of time between these blood draws for women. Because women developed
presyncopal symptoms near the time of the second blood draw, the pre-syncopal (3rd
draw) blood draw often occurred right after (usually within 2 minutes) this second blood
draw. Men have a larger TP concentration at the time of their pre-syncopal blood draw
because they were able to withstand a longer stress, allowing for more fluid filtration.
Arginine vasopressin increased with increasing orthostatic stress in men (although
these small changes were not large enough to impact blood pressure regulation), but did
not change in women. Also, men had higher levels of AVP than did women. This has
been supported by other researchers (74, 114), and an inability of women to rely on AVP
response to orthostatic stress might be one of the factors involved in their overall reduced
tolerance to LBNP. Men had smaller AVP responses to stress after AG training, although
their control values were not different. This could be evidence that AG-trained men
relied more on neurally-mediated peripheral vascular responses to maintain tolerance
rather than through neurohumoral responses.

Spectral Power
Low frequency (0.04 – 0.15 Hz) spectral power of blood pressure increased in all
subjects in response to orthostatic stress (control and recovery < HUT < -20 mmHg
LBNP and LST4), Figure 4.18.

This was an expected result, indicating increased

sympathetic nervous system activity with the onset of orthostatic stress. Low frequency
oscillations in arterial pressure and RR interval have been directly correlated to
oscillations in sympathetic nerve discharge (52, 98). In our study, this index of increased
sympathetic activity was supported by increased circulating norepinephrine in all subjects
during blood draws at -30 mmHg LBNP and ninety seconds after presyncopal symptoms
developed, and increased epinephrine in all male subjects (female epinephrine data was
unavailable).
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These low frequency oscillations in blood pressure are most likely caused by low
frequency oscillations in vascular resistance (78, 115, 116). This study showed increased
LF TPR spectral power during all levels of orthostatic stress (HUT, -20 mmHg LBNP,
LST4) compared to supine control and recovery. Women had a higher LF TPR response
to HUT than did men after training, indicating that women had higher sympathetic
regulation of blood pressure after AG training. This higher LF TPR response to HUT
was present in both female groups, and did not differentiate between active and passive
subjects. In active women, there was no change in mean TPR after training, unlike the
other training groups, indicating that enhanced vasomotion may have played some role in
improving tolerance to HUT in active women.
Another index of autonomic regulation is high frequency (0.15 – 0.40 Hz) spectral
power of heart rate and blood pressure. In contrast to LF power, a decrease in HF power
has been shown to correlate with decreased parasympathetic outflow (52). This is seen in
the current group of subjects as a decrease in HF heart rate power during -20 mmHg
LBNP and LST4, compared to supine control and recovery, Figure 4.22a. Women had
significantly higher HF arterial pressure power and nearly higher heart rate HF power
than men (p = 0.07, Figure 4.22b). Increased AP high frequency power could be a direct
effect of breathing (106) and higher HR HF could indicate that women had greater vagal,
rather than sympathetic, control of heart rate. This is not an uncommon finding, and has
been suggested by several researchers (23, 41, 49). Additionally, women decreased HF
arterial pressure power after training, perhaps indicating higher sympathetic control of
blood pressure. Changes in HF arterial pressure power coupled with a HUT-induced
increase in LF TPR power after training suggests that female subjects may have
responded to AG training by increasing sympathetic regulation of blood pressure, with
less reliance on parasympathetic control. Overall, however, women had a higher index of
parasympathetic control (HF heart rate), which is probably one of the reasons they have
overall less tolerance to orthostatic stress than do men (49).

Baroreflex Activity
Analysis of the cardiac baroreflex response before and after training, as well as
during training, also provides insight into the effects of artificial gravity training on
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cardiovascular responses to orthostatic stress. Decreases in baroreflex sensitivity and
increases in the normalized number of sequences from supine control to head-up tilt were
expected, and are well documented (4, 72, 73, 117). However, there were no differences
in BRS or NNS between supine control (0 Gz) and supine 1 Gz rotation. This implies that
1 Gz rotation does not stimulate carotid or aortic baroreceptors above the level of that
measured for supine control. Rotation producing 2.5 Gz at the feet was required to shift
enough fluid to unload cardiac baroreceptors in order to stimulate a response equivalent
to 70º HUT. Watenpaugh et al suggested that (on a 1.8 m centrifuge), 5 Gz might be
needed at the feet to elicit a response similar to standing (132), but the present study
verified that 2.5 Gz on a 1.9 m centrifuge was sufficient to accomplish this.
There was some variability associated with subject’s heights; however, in general
1.0 Gz at the feet is approximately 0.2 to 0.25 Gz at the heart level, and even smaller at
the carotid baroreceptors. Similarly, 2.5 Gz acceleration at the feet does not produce 1.0
Gz at the heart; it is approximately 0.7 to 0.75 Gz at the heart. Based on these physical
calculations alone, one would not expect 2.5 Gz (at the feet) acceleration to stimulate the
cardiac baroreceptors as much as 70º HUT (sin70º * 1Gz ≈ 0.94 Gz), yet our spontaneous
baroreflex analysis would suggest otherwise. This could be caused by indirect unloading
of the baroreceptors by fluid sequestering in the legs due to the 2.5 Gz at the feet.
Although the gravity gradient along the body is linearly related to radial distance from the
center of centrifugation, the hydrostatic gradient is non-linear (ω2r2 as opposed to ω2r).
This causes a large shift of fluid to the feet, which could unload the baroreceptors and
explain the similarity in baroreflex responses at supine 2.5 Gz and 70º HUT.
It is possible that these AG training-induced shifts of fluid to the feet stimulate
cardiopulmonary baroreceptors more than aortic or cardiac baroreceptors. These lowpressure receptors act mainly through sympathetic stimulation of the vasculature (105),
which might explain the enhanced vascular resistance responses seen in our active
subjects after training.
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Responses to OLBNP
One of the “regulated” variables during cardiovascular stress is blood pressure.
Previous studies analyzing the control of blood pressure in dogs exposed to sinusoidal
acceleration at frequencies similar to this study indicated that AP was centrally regulated
at very low frequencies (below 0.012 Hz), and that these central mechanisms were less
effective at higher frequencies (82, 103). More recent human studies using oscillatory
lower body negative pressure yielded similar results (88). Brown et al determined that
cerebral blood vessels were unable to modulate fluctuations in arterial pressure (in
response to OLBNP), and that this effect was more pronounced at higher frequencies .
Levenhagen et al determined in a similar group of ambulatory men, that arterial pressure
fluctuations were minimized at all OLNBP input frequencies.

However, when the

amplitude of arterial pressure oscillations were normalized by the amplitude of fluid
volume shifted (either calf circumference or central venous pressure oscillations), AP
amplitudes increased with increasing input frequencies, peaking at 0.08 Hz (88).
Similar to Levenhagen et al, our results show relatively stable (<3 mmHg) AP
amplitudes across the range of input OLBNP frequencies. Amplitudes at 0.10 and 0.125
Hz were slightly lower than at 0.01 Hz, indicating either smaller volume of fluid was
being shifted or enhanced regulation occurred at higher frequencies. In the present study,
the largest amplitude responses occurred at 0.04 Hz and this could be the effect of TPR
timing in response to OLBNP—both AP and TPR were in phase at this frequency,
meaning maximum vasoconstriction was occurring in sync with maximum blood
pressure, which could yield larger oscillations in AP (Figures 4.32 and 4.46). Also
similar to Levenhagen, normalization of AP amplitudes with changes in CC indicated
reduced control of blood pressure at higher input frequencies, Figure 5.1. Overall, our
results support the concept that healthy, ambulatory subjects regulated blood pressure
quite well in spite of large oscillations in cardiac output at lower frequencies and reduced
control at higher frequencies, where smaller oscillations in fluid volume appear to be the
principal factor.
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Figure 0.1: AP amplitudes normalized by CC amplitudes for all subjects.

The phase response of AP was also similar to the human OLBNP study (88).
Arterial pressure consistently lagged OLBNP input by approximately 180º, except at 0.08
Hz, where it was about 210º out of phase. This indicated that blood pressure fell as
vacuum was applied, as would be expected.
Levenhagen et al reported decreasing HR amplitudes with increasing OLBNP
input frequencies. This study yielded similar results from 0.01 to 0.04 Hz, with no
changes in amplitude response at higher input frequencies. It is important to note,
however, that this study analyzed frequencies higher than those used by Levenhagen et al
(0.125 and 0.15 Hz), and no predictions can be made about trends from their data past
0.10 Hz. This decrease in amplitude with increasing frequency has been suggested as a
decrease in central neural control; current results (no change in HR amplitude from 0.04
to 0.15 Hz) suggest no change in neural control, possibly due to the minimal fluid shifts
at higher input frequencies. However, examination of the HR phase response suggests
that HR is responding as needed; even though phase lags were larger at faster input
frequencies, the actual response time of maximum HR to the maximum pull of OLBNP at
the 4 fastest frequencies averaged 5 seconds, which is faster than the HR responses to
input frequencies from 0.01 to 0.04 Hz. Another interesting observation from timing data
(as opposed to phase lags in degrees) is that men had a significantly slower HR response
to OLBNP input than do women (Figure 5.2), implying that heart rate (known to be
capable of reflex changes in a second) was actually participating in blood pressure
regulation by buffering other variables that were slower to act in men than in women.
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Figure 0.2: Heart response time to OLBNP input for men and women

This difference in HR response times in men and women was a main effect of the
ANOVA, but it can be seen that this is an effect of the low frequency (0.01 – 0.04 Hz)
inputs. This is another indication that women respond more vagally than do men, or,
possibly that women were more stressed than men were at these low LBNP frequencies.
It is possible that women were more stressed at these low LBNP input frequencies, as
active women had larger blood pressure oscillations at 0.04 Hz than did active men, and
passive women had larger blood pressure oscillations at 0.01 Hz than did passive men,
Figure 4.31b. An interesting corollary to this difference in HR timing is the timing
response of TPR to OLBNP, Figure 5.3. Although not statistically significant, there is a
trend for male TPR responses to be faster than female responses, again suggesting that
men have a stronger (faster) sympathetic response to stress than do women. However,
women had larger TPR amplitude response than did men at all frequencies (Figure
4.45b); this might be interpreted as women having larger sympathetic responses, or more
likely that women were being stressed more severely during LBNP than were men (93,
138, 139).
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Figure 0.3: TPR timing response to OLBNP input for men and women.

The forcing function used in this test was oscillatory lower body negative
pressure; however, in response to OLBNP, the perturbation to the cardiovascular system
is actually shifting of fluid from the upper body to the lower body. In this study, an index
of this shift is a change in calf circumference. Slower input frequencies allow more time
for fluid to accumulate in the calf, and this is seen in the larger amplitude responses at
lower input frequencies, Figure 4.48a. As input frequency increased, CC amplitude
decreased from 0.01 to 0.08 Hz, as there was less time for fluid to build up in the calf.
From 0.08 to 0.15 Hz, there was no change in the amplitude response of CC, indicating
no difference in pooling in the lower leg during these frequencies. Swelling of the calf
during short-term (less than 10 minutes) LBNP appeared to be dominated by shifting of
fluid to venous spaces (2, 8), and not likely caused by filtration into interstitial spaces.
However, the results from the present study indicate a difference in the amount of blood
pooled at low versus high input frequencies. It is possible that filtration into interstitial
places may contribute to the amount of fluid shifted for frequencies below 0.08 Hz
(period of 12 seconds), which accounts for the larger changes in CC at lower than 0.08
Hz input frequencies; at higher frequencies, it is likely that a significant amount of
filtration does not occur within 6 to 12 seconds of LBNP (0.15 to 0.08 Hz), which could
explain why CC amplitudes do not further change with increasing frequencies above 0.08
Hz.
As OLBNP input frequency increased from 0.01 to 0.08 Hz, CC tended to fall
farther out of phase (Figure 4.49) while, from 0.08 to 0.15 Hz, there was no change in CC
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phase lag with respect to input frequency.

However, a steady phase response to

increasing frequency indicates a decrease in timing in the time domain. Although there
were no amplitude or phase changes in input frequencies from 0.08 Hz to 0.15 Hz, the
calf circumference changes faster in response to faster input frequency, indicating that
vascular fluid shifts keep up with the OLBNP stimulus.
After active training, phase lag tended to be diminished (p = 0.09 overall, p < 0.05
for 0.08, 0.10 and 0.125 Hz inputs, Figure 4.50a). Although not a significant effect, the
passive subjects responded in an opposite fashion, tending to increase phase lag after
training, Figure 4.50b. This increased speed of response after active training could imply
increased vascular compliance, yielding a larger change in volume for smaller pressure
changes (thereby making the calf swell faster with the onset of LBNP); or decreased CC
response time could be the effect of a larger vascular bed (large muscles) after active
training. A larger vascular bed might be construed to be detrimental to maintaining
orthostatic tolerance, but other results indicate a positive effect of training. For example,
active men significantly reduced TPR phase lag (at all input frequencies) after training,
indicating enhanced responsiveness to OLBNP.
One could argue that the increased response time of TPR after training is simply a
response to faster changes in CC dynamics; however, this is not the case. By subtracting
CC phase values from TPR phase, one can calculate the vascular resistance response to
shifting of fluid to the calf. In doing this, the active men significantly decreased (p =
0.01) TPR response time to changes in CC, while active women significantly increased (p
= 0.02) TPR response time to changes in CC after training, Figure 5.4.

Figure 0.4: TPR phase response to changes in CC for active men (left) and women (right), before and
after AG training.
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While not significant (p = 0.08), women’s TPR response to CC changes tended to
be slower than men’s. This slower TPR response to CC changes is independent of
training, and could be a reason for decreased orthostatic tolerance in women. As stated
above, a predominance of literature indicates that men’s cardiovascular control is
sympathetically dominated, while women respond more vagally. With these findings in
mind, comparisons of response times of both TPR and HR to changes in AP were made.
Similar to the response to changes in CC, TPR responded faster to changes in AP after
training than before in active men (p = 0.02). There were no differences in TPR response
times to AP changes in women, although passive men increased TPR response time
(slower responses) to changes in AP. If the vascular resistance response to changes in AP
is an indicator of training efficacy, then this is strong evidence that exercise is an
important aspect of AG training in men.
Unlike the increased responsiveness of TPR to AP changes, HR responses to
changes in AP were more sluggish after training (in all subjects), Figure 5.5.

Figure 0.5: Heart rate responses to changs in blood pressure before (blue) and after (red) training for
all subjects.

This could be a result of the ‘decoupling’ effect of AG training – improved
tolerance via peripheral mechanisms without improvement in cardiac baroreflex
(discussed below) responses. The increased response time (slower response) of HR to
changes in AP was associated with a decrease in HR amplitude at 0.01 Hz for all active
subjects after training, Figure 4.35a. Although there was no effect of training or gender,
0.01 Hz was the only frequency at which OLBNP induced a faster response in TPR than
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in HR. It could be that the body chooses to respond to disturbances in AP via vascular
mechanisms, but is unable to do so at higher frequencies.
These TPR and HR results are opposite of those found by Charles, in which
oscillatory fluid shifts via centrifugation were assessed in two groups (endurance
exercised trained versus control) chronically instrumented dogs (18). The conclusions
from this dog study were that endurance trained dogs had slower TPR responses after
training, and these endurance trained dogs relied more on HR to buffer changes in blood
pressure. The differences between these two studies could be a result of: 1) species,
Charles studied dogs rather than humans, 2) stimulus, Charles used acceleration on a
centrifuge to cause fluid shifts while this study used LBNP and 3) training paradigm, the
endurance trained dogs in Charles’ study were trained in a normal 1 Gz environment
(treadmill at a 10º incline) while the active men in the present study were trained in an
oscillatory, but rotational Gz environment.

Limitations
Although this study was able to show that artificial gravity training was beneficial
in improving orthostatic tolerance in normal, ambulatory subjects, the subject pool was
not controlled in any way. Subjects arrived daily for their training session, then resumed
their normal lives, so strict experimental control of subjects was not maintained.
Secondly, MV02 was not assessed, so, even though subjects and input loads were
matched to that of the 1999 study where this assessment was made, heart rate reached
during the effort to drive the centrifuge was our only direct assessment of how hard each
subject was working. Thirdly, even though subjects were randomly assigned to groups,
the active female group was more athletic and “in shape” then were the passive females.
Our HUT/LBNP termination point was subject to a large number of factors,
including drops in blood pressure and heart rate, as well several measures of subject
discomfort; stomach awareness, light-headedness, sweating or general discomfort. While
the same medical monitor was used for the duration of the study, so that the same presyncopal symptoms were identified both before and training, fewer than half the subjects
did not exhibit the classic drops in blood pressure and heart rate associated with
vasovagal syncope, but for other reasons mentioned above the test was terminated. .
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Another limitation of this study was a lack of plasma volume measurements.
Other studies have showed changes in plasma and/or blood volumes associated with
centrifuge studying, and it is unclear if these volume changes are associated with
improved tolerance.

Additionally, women’s epinephrine and dopamine data were

contaminated during analysis, and were not suitable for use in this document.
Finally, there are some aspects of blood pressure regulation that may have been
effected by AG training which were not measured in this study. For example, improved
orthostatic tolerance may have been the result of enhanced cerebral autoregulation (148),
although much of the evidence in this study points peripheral vasculature mechanisms.
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Chapter 6: Conclusions
The hypothesis of this study was that 3 weeks of artificial gravity training would
improve orthostatic tolerance in normal, ambulatory subjects. The results of this study
indicated that this hypothesis was correct; three weeks of training improved orthostatic
tolerance by 13% in a group of 26 subjects. Men were more tolerant to orthostatic stress
than were women, both before and after training and men had higher blood pressure,
stroke volume, end diastolic volume and cardiac output than did women Active subjects,
regardless of gender, were more improved than their passive counterparts.
Improved tolerance (of the whole group of subjects) was associated with
decreased blood pressure and total peripheral resistance after training, as well as
increased stroke volume. Improved tolerance in active subjects was associated with
larger residual calf circumferences during recovery after training, as well as faster CC
and TPR responses to OLBNP input after training. After training, all subjects had slower
HR responses to changes in AP.
These mechanisms associated with improved tolerance are not a result of
increased cardiac baroreflex activity, as there were no BRS or NNS changes posttraining. Also, spontaneous baroreflex analysis yielded no differences between supine
control and supine 1.0 Gz acceleration, nor between 70º HUT and 2.5 Gz acceleration,
suggesting that mechanisms other than centrally mediated cardiac baroreflex are
responsible for any artificial gravity training effects.
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Chapter 7: Future Work
While this study was successful in improving orthostatic tolerance in normal,
ambulatory subjects, the impetus behind this research was development of a
countermeasure to orthostatic intolerance associated with cardiovascular deconditioning
in spaceflight. A well documented analog of cardiovascular alterations to microgravity is
extended bed rest in a 6º head down position. Future research should be performed to
assess the efficacy of artificial gravity training in preventing any detrimental effects
associated with these adaptations to microgravity.
Additionally, duration, frequency and intensity of AG training needs to be
examined in order to determine the best combination of exercise and AG training for its
use a practical countermeasure. In optimizing these parameters, new methods of analysis
should be utilized to determine the effects of AG training. Specifically, segmental body
impedance should be used to assess fluid volume shifts not only during a provocative
HUT/LBNP test, but also during AG training. This type of analysis would help to
answer previously unexplored aspects of AG training, such as volume changes in
different regions of the body under varying levels of AG and exercise.
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Appendices
Appendix A: Subject and Data File information
Table 1: Anthropomorphic Data for All Subjects
Training
Age
Gender
Group
(yr)
Height (cm)
A
male
active
24
180
B
male
passive
37
182
C
male
passive
50
180
D
male
active
37
184
E
male
passive
34
178
F
male
passive
34
173
G
male
active
34
187
H
male
passive
30
155
I
male
active
29
183
J
male
active
46
170
K
male
active
21
173
L
male
active
29
188
M
male
passive
32
176
N
male
passive
26
180
O
male
passive
27
188
AW
female
passive
37
163
BW
female
passive
29
171
CW
female
active
35
172
DW
female
passive
28
164
EW
female
active
25
159
FW
female
passive
39
164
GW
female
active
29
184
HW
female
active
22
169
IW
female
passive
27
158
JW
female
passive
26
147
KW
female
active
31
170
LW
female
active
34
142
MW
female
passive
28
159
NW
female
active
44
168
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Weight
(kg)
82
73
100
71
80
72
86
77
84
73
82
89
78
82
90
62
57
60
52
58
56
65
61
72
51
62
83
55
71

Table 2: Channel Assignments for Data Processing
Channel
Variable
1
Arterial Pressure
2
Systolic Pressure
3
Diastolic Pressure
4
Mean Arterial Pressure
5
ECG
6
Heart Rate
7
RR Interval
8
Stroke Volume
9
Cardiac Output
10
End Diastolic Volume
11
Thoracic Fluid Index
12
Calf Circumference
13
Tilt Angle
14
LBNP Level
15
Palm Skin Perfusion
16
Forearm Skin Perfusion
17
Palm Skin Velocity
18
Forearm Skin Velocity
19
Palm CMBC
20
Forearm CMBC
21
Total Peripheral Resistance
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Appendix B: Statistics Code
Example SAS code to calculate 4 factor ANOVA
**************************************************;
* two within and two between subjects factors;
**************************************************;
options ls=200 ps=10000 nonumber nodate;
data one;
input id $ y1-y7;
line + 1;
gender = ' MEN ';
if line > 28 then gender = 'WOMEN';
protocol = 'ACTIVE ';
if line > 14 then protocol = 'PASSIVE';
if line > 28 then protocol = 'ACTIVE ';
if line > 40 then protocol = 'PASSIVE';
day = ' BEFORE';
if line > 7 then day = ' AFTER ';
if line > 14 then day = ' BEFORE';
if line > 21 then day = ' AFTER ';
if line > 28 then day = ' BEFORE';
if line > 34 then day = ' AFTER ';
if line > 40 then day = ' BEFORE';
if line > 45 then day = ' AFTER ';
id_m=substr(id,1,4);
cards;
DATA GOES HERE.
;
run;
proc print data=one;
*var gender day id y1-y7;
title OLBNP Analysis;
run;
data two;
set one;
seg = '0.010Hz'; y = y1; output;
seg = '0.020Hz'; y = y2; output;
seg = '0.040Hz'; y = y3; output;
seg = '0.080Hz'; y = y4; output;
seg = '0.100Hz'; y = y5; output;
seg = '0.125Hz'; y = y6; output;
seg = '0.150Hz'; y = y7; output;
run;
proc means data=two n mean std stderr noprint;
class gender day protocol seg;
var y;
output out=two_means n=n mean=y_mean std=y_sd stderr=y_sem;
title 'mean responses by each treatment combination';
run;
proc print data=two_means noobs;

84

where gender ne ' ' and day ne ' ' and protocol ne ' ' and seg ne ' ';
var gender day protocol seg n y_mean y_sd y_sem;
run;
proc mixed data=two covtest;
class gender day protocol seg id_m;
model y = gender| day| protocol| seg / ddfm = satterth ;
random id_m(gender*protocol) seg*id_m(gender*protocol)
day*id_m(gender*protocol);
title 'mixed linear model';
run;
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Appendix C: Mean and Spectral Power Data Results for HUT/LBNP Data

Table 3: Arterial Pressure Means (mmHg)
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Table 4: Low Frequency Arterial Pressure Spectral Power (mmHg2)
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Table 5: High Frequency Arterial Pressure Spectral Power (mmHg2)
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Table 6: Heart Rate Means (beats per minute)
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Table 7: Low Frequency Heart Rate Spectral Power (bpm2)
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Table 8: High Frequency Heart Rate Spectral Power (bpm2)
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Table 9: Total Peripheral Resistance Means (mmHg/L/min)
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Table 10: Low Frequency Total Peripheral Resistance Spectral Power (mmHg/L/min)2
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Table 11: High Frequency Total Peripheral Resistance Spectral Power (mmHg/L/min)2
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Table 12: Stroke Volume Means (mL)
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Table 13: Low Frequency Stroke Volume Spectral Power (mL2)
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Table 14: High Frequency Stroke Volume Spectral Power (mL2)
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Table 15: Cardiac Output Means (L/min)
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Table 16: Low Frequency Cardiac Output Spectral Power (L/min)2
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Table 17: High Frequency Cardiac Output Spectral Power (L/min)2
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Table 18: End Diastolic Volume Means (mL)
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Table 19: Low Frequency End Diastolic Volume Spectral Power (mL)2
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Table 20: High Frequency End Diastolic Volume Spectral Power (mL)2
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Appendix D: Amplitude and Phase of OLBNP Data
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Table 21: Arterial Pressure Amplitudes (mmHg)
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Table 22: Arterial Pressure Phase Lags (degrees)

106

Table 23: Calf Circumference Amplitudes (% change)
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Table 24: Calf Circumference Phase Lags (degrees)
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Table 25: Heart Rate Amplitudes (beats per minute)
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Table 26: Heart Rate Phase Lags (degrees)
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Table 27: Total Peripheral Resistance Amplitudes (mmHg/L/min)
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Table 28: Total Peripheral Resistance Phase Lags (degrees)
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Table 29: Stroke Volume Amplitudes (mL)
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Table 30: Stroke Volume Phase Lags (degrees)
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Table 31: Cardiac Output Amplitudes (L/min)
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Table 32: Cardiac Output Phase Lags (degrees)
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Table 33: End Diastolic Volume Amplitudes (mL)
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Table 34: End Diastolic Volume Phase Lags (degrees)
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